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Many abundant and highly bioactive natural alkaloids contain an indolizidine skeleton. A simple, high
yielding method to synthesize this scaﬀold from N-heterocycles was developed. A wide range of
pyridines, quinolines and isoquinolines reacted with donor–acceptor (DA)-aminocyclopropanes via an
ytterbium(III) catalyzed [3 + 2] annulation reaction to give tetrahydroindolizine derivatives. The products
were obtained with high diastereoselectivities (dr > 20 : 1) as anti-isomers. Additionally, the formed
aminals could be easily converted into secondary and tertiary amines through iminium formation
followed by reduction or nucleophile addition. This transformation constitutes the ﬁrst example of
dearomatization of electron-poor six-membered heterocycles via [3 + 2] annulation with DA
cyclopropanes.1. Introduction
The indolizidine skeleton is widely represented in bioactive
alkaloids.1 For example, castanospermine (1, Scheme 1) is
a potent inhibitor of a-glucosidase I, an enzyme with a critical
role in viral maturation, and was the lead structure for celgosivir
which is currently under investigation for treatment of hepatitis
C virus infection and dengue fever.2 The indolizidine class of
natural products also includes more complex polycyclic
compounds incorporating further fused saturated or unsatu-
rated rings.3 For instance, isoschizogaline (2) contains
a reduced quinoline core structure,3a whereas jamtine (3)3b or
haiderine (4)3c can be seen as isoquinoline derived alkaloids.
The construction of these polycyclic scaﬀolds by dearomatiza-
tion of quinolines, isoquinolines or pyridines is highly attrac-
tive, due to the broad availability of the unsaturated
heterocycles. Classic dearomatization strategies most oen rely
on the formation of a single bond, starting from activated pyr-
idinium or (iso)quinolinium intermediates.4 Dearomatization
reactions through direct annulation via ring-extension ofhesis, Institut des Sciences et Inge´nierie
e de Lausanne, CH-1015 Lausanne,
ESI) available. CCDC 1556244. For ESI
other electronic format see DOI:
cientic career and cannot be contacted
al version of this manuscript. Based on
both J. P. and J. W. agree to include him
ould agree to be included if he knewcyclopropanes would provide a more convergent synthesis
(Scheme 1). Nevertheless, such processes are unknown.5
In this context, Lewis acid (LA) catalyzed [3 + 2] annulation
reactions of donor–acceptor (DA) cyclopropanes with dipolar-
ophiles have been intensively studied.6 In particular, these
reactions are highly successful with enol-ethers,7
nitrosoarenes,8 imines,9 heteroatom substituted alkynes,10
carbonyl compounds11 and nitrones.12 However, dearomative
[3 + 2] annulation reactions were only intensively studied with
indoles13 and a single example was reported for benzothiazoles
(Scheme 2).14 Therefore, only [6,5,5] polycyclic ring systems can
be currently accessed, although this approach would appear
highly attractive for the synthesis of other polycyclic scaﬀolds as
well. In fact, indole, with its high nucleophilicity and low
aromatization energy (28 kcal mol1 only for the pyrrole ring),15
constitutes an ideal case for dearomatization reactions: the
nucleophilic character leads to a fast reaction with Lewis acid
activated DA cyclopropanes, and the lower aromatization energy
makes isolation of the saturated products easier.Scheme 1 Examples for indolizidine containing natural products and
general retrosynthetic scheme.
This journal is © The Royal Society of Chemistry 2017
Scheme 2 Dearomatization via [3 + 2] annulations with DA-
cyclopropanes.
Scheme 3 Preliminary results on the dearomatization of quinoline (8).
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
A
ug
us
t 2
01
7.
 D
ow
nl
oa
de
d 
on
 2
8/
03
/2
01
8 
14
:1
2:
41
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineDearomatizing electron-poor quinolines with higher
aromatization energy (35 kcal mol1 for the pyridine ring) is
much more challenging. In 2006, Pagenkopf and coworkers
reported a method for the formation of indolizines via [3 + 2]
annulation of pyridines or quinolines with DA cyclopropanes.16a
In this work, dihydroindolizines were observed as intermedi-
ates, but they could be only isolated in very low yield and
partially oxidized to indolizines. Therefore, the authors decided
to completely aromatize the crude product with manganese(IV)
oxide to obtain single, clean products. Later, Wang and co-
workers used a similar approach with iodine as oxidant for
indolizine synthesis.16b
Compared to bicyclic aromatic compounds, the dearomati-
zation of monocyclic aromatics is even more challenging due to
increased resonance stabilization. It is therefore not surprising
that no dearomatizing [3 + 2] annulation was yet reported for
these compounds.
Herein we describe the dearomative [3 + 2] annulation of
N-heterocycles with aminocyclopropanes to generate tetra-
hydroindolizines with high yield and stereoselectivity. Key
for success were the exceptional properties of imido-
substituted DA diester cyclopropanes, as other types of
donor groups were not successful. A broad substrate scope
including pyridines, quinolines, and isoquinolines is pre-
sented. The obtained aminals can be easily modied through
iminium formation and subsequent reduction or nucleophile
addition.This journal is © The Royal Society of Chemistry 20172. Results and discussion
2.1. Preliminary results and optimization
We started our investigations by examining the reactions of DA
acceptor cyclopropanes with quinoline (8) using scandium tri-
ate as a Lewis acid catalyst (Scheme 3). Under these condi-
tions, no reactivity was observed using well-established aryl-
substituted DA cyclopropane 13.6 We then wondered if DA
cyclopropanes bearing a heteroatom donor group would be
more reactive.7c Indeed, cyclopropane 14 bearing a phthalimide
donor led to the formation of [3 + 2] annulation product 17 in
80% yield. Cyclopropane 14 is easily available in one step on
multigram scale from N-vinylphthalimide and diazomalonates
by Rh-catalyzed cyclopropanation.17 In contrast, no conversion
was observed with cyclopropane 15 bearing an oxygen donating
group. This results further highlight the unique reactivity of
imido-substituted DA cyclopropanes. Gratifyingly, compound
17 was stable enough to be isolated and fully characterized. The
cis-relationship of the phthalimide and the hydrogen at ring
junction was conrmed by X-ray analysis (Fig. 1).18
We then turned to the optimization of the [3 + 2] annulation.
Product 17 was formed with >20 : 1 anti diastereoselectivity and
80% yield using Sc(OTf)3 as catalyst (Table 1, entry 1). Neverthe-
less, this result could only be obtained with 1.5 equiv. of cyclo-
propane 14 and relatively low molarity (0.05 M) to prevent
decomposition. Furthermore, the amount of Sc(OTf)3 could not
be reduced. Therefore, other Lewis acids were examined. No
reaction was observedwith In(OTf)3 or Cu(OTf)2 as catalysts (Table
1, entries 2 and 3) whereas the use of Hf(OTf)4 resulted in full
decomposition of the DA-cyclopropane 14 (Table 1, entry 4). Better
results were obtained using Yb(OTf)3 as catalyst. A rst experi-
ment gave 90% of the desired product 17 while the high diaster-
eoselectivity was maintained (Table 1, entry 5). Furthermore, the
mild conditions with Yb(OTf)3 allowed us to conduct the reaction
more concentrated (0.5 M), with only 1.05 equivalents 14 and at
lower catalyst loading (5 mol%) without observing any decrease in
yield (Table 1, entry 6).19 The reaction proved to be easily scalable,
as the yield did not change on 2 mmol scale. Eventual Brønsted
acid catalysis of the reaction could be excluded by a control
experiment with triic acid (Table 1, entry 7). No reaction between
8 and para-methoxy phenyl or acetate substituted DA cyclopro-
panes (13 and 15) was again observed in presence of catalytic
amounts of ytterbium(III) triate (Table 1, entries 8 and 9).Chem. Sci., 2017, 8, 7112–7118 | 7113
Fig. 1 Structure of compound 17 as determined by X-ray analysis.
Some hydrogen atoms are omitted for clarity.
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View Article Online2.2. Scope of the [3 + 2] annulation
Next, the scope of the reaction was examined by submitting
various quinolines to the optimized reaction conditions (Fig. 2).
Substitution of the pyridine ring was examined rst (Fig. 2A).
Alkyl, alkynyl and halogen substituents were all well tolerated
either in C3 or C4 position of the quinoline ring (products 20–
25). To our delight, O-acetylated cinchonidine with its highly
basic amine worked well and furnished compound 22 in 76%
yield and 1 : 1 dr. A broad range of versatile substituents such as
aryl, halogens, triuoromethyl, ester, nitrile and nitro were also
tolerated on the arene ring (Fig. 2B, products 26–34). Generally,
no diﬀerences in term of reactivity were observed upon substi-
tution of the benzene or the pyridine ring of the employed
quinolines. Only 2- and 8-substituted quinolines did not reactTable 1 Optimization of the dearomative [3 + 2] annulation reaction
of quinoline 8 and DA cyclopropanes 13–15a
Entry R LA Mol% Yieldb
1 NPhth Sc(OTf)3 20 80
2 NPhth In(OTf)3 20 No conversion
3 NPhth Cu(OTf)2 20 No conversion
4 NPhth Hf(OTf)4 20 Decomposition
5 NPhth Yb(OTf)3 20 90
6c NPhth Yb(OTf)3 5 96 (95)
d
7e NPhth TfOH 20 No conversion
8 PMP Yb(OTf)3 20 No conversion
9 OAc Yb(OTf)3 20 No conversion
a Reactions were carried out on 0.10 mmol scale with 1.5 equiv. of 13–15
in CH2Cl2 (0.05 M).
b Isolated yields. c Reaction was carried out on
0.20 mmol scale with 1.05 equiv. of 14 in CH2Cl2 (0.50 M).
d Reaction
was carried out on 2.00 mmol scale with 1.05 equiv. of 14 in CH2Cl2
(0.50 M). e 0.2 M in CH2Cl2. Phth ¼ phthalimide, Tf ¼
triuoromethylsulfonyl, PMP ¼ para methoxyphenyl.
7114 | Chem. Sci., 2017, 8, 7112–7118under the developed conditions (with the exception of the u-
oro substituent, product 31), probably due to increased steric
hindrance. As a limitation, dearomatization of highly electron-
rich 6-methoxy quinoline was not successful and compound 33
could not be obtained. Overall, the tolerance of functional
groups attached to the quinoline is extremely broad, including
in particular:
- Potentially sensitive p-systems, such as alkenes and alkynes
(products 22, 24 and 25).
- Strongly electron-withdrawing groups, such as esters, cyano
and nitro, which are useful precursors of amides or amines
(products 29, 30 and 34).
- Halogens, which are easily further modied using cross-
coupling chemistry (products 20 and 26) or useful to diminish
the electron-density of the heterocycle for pharmaceutical or
agrochemical purposes (especially uorine, products 27 and 31)
- Highly basic tertiary amines (product 22).
The inuence of diﬀerent nitrogen substituents on the
DA-cyclopropane was then investigated (Fig. 2C). Less electron
donating phthalimide groups with chloro or nitro substituents
gave the desired products 35 and 36 in good yields, but their
stability was signicantly lower compared to their unsub-
stituted relative 17. Furthermore, maleimide, succinimide or
a 2,3-naphthimide substituted DA cyclopropanes could also be
used under the developed conditions (products 37–39). Finally,
diﬀerent ester groups on the cyclopropane had low impact on
the reaction outcome (Fig. 2D): replacing the methyl esters of 14
with benzyl or triuoroethyl esters gave the desired products 40
and 41 in excellent yields. With a mixed diester, product 42 was
isolated in 72% yield, and 3.5 : 1 dr at the additional stereogenic
center.
At this point we wondered if the developed protocol for the
dearomatization of quinoline could also be applied to other N-
heterocycles. To our delight isoquinoline reacted equally well
and furnished 43 with 83% yield and high diastereoselectivity
(>20 : 1, Fig. 3A). Cyano and ester substituted isoquinolines
reacted also well under the developed conditions (products 44
and 45). The scope of the reaction could be extended to ben-
zothiazole and benzoxazole (Fig. 3B, products 46 and 47).
Further expansion of the scope to pyridines proved to be
more diﬃcult. Unsubstituted pyridines or pyridines with elec-
tron donating substituents did not react to form the desired
products under the developed conditions. It is known, that
nucleophilic ring opening of acceptor substituted cyclopro-
panes with pyridine furnishes betaine products.20 Ring closure
was expected to be more favored with electron decient pyri-
dines, as the positive charge of the betaine intermediate is then
less stabilized. Indeed, the desired dearomative [3 + 2] annu-
lation products of electron-decient pyridines and 6a were
isolated with good yield and high diastereoselectivity (>20 : 1)
when the catalyst loading was raised to 10 mol% and the
concentration to 1 M (Fig. 3C). Nicotinonitrile as well as iso-
nicotinonitrile gave the desired products 48 and 49 with high
yield. 4-Methyl, bromo-, or alkyl-substituted nicotinonitrile
could also be used (products 50–52). Remarkably, the annula-
tion reaction was completely regioselective for the less sterically
hindered position. Such a high selectivity has been only rarelyThis journal is © The Royal Society of Chemistry 2017
Fig. 2 Scope of the [3 + 2] annulation with quinolines. Reaction conditions: quinoline (0.20 mmol), DA-cyclopropane (0.21 mmol), Yb(OTf)3
(5 mol%), CH2Cl2 (0.5 M). Unless noted otherwise products obtained with dr > 20 : 1. Phth ¼ phthalimide, TBS ¼ tert-butyldimethylsilyl.
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View Article Onlinereported for addition to pyridinium salts.4h Ethyl nicotinate
derivative 53 could not be obtained, but 3,4- and 3,5-diester
substituted pyridines gave the desired products 54 and 55 in
good yields. Alternatively, installation of a more electron-Fig. 3 Reaction conditions: N-heterocycle (0.20 mmol), 14
(0.21 mmol), Yb(OTf)3 (5 mol%), CH2Cl2 (0.5 M). Unless noted other-
wise products obtained with dr > 20 : 1. aChanges from normal
reaction conditions: Yb(OTf)3 (10 mol%), CH2Cl2 (1 M).
b1 mmol scale.
Phth ¼ phthalimide, TBS ¼ tert-butyldimethylsilyl.
This journal is © The Royal Society of Chemistry 2017withdrawing HFIP ester was also successful (product 56).
These active esters can be readily converted into diﬀerent
amides and esters.21 Other electron-withdrawing groups on the
nicotinate also led to good yields (products 57 and 58). Finally,
nitro-substituted pyridines also furnished the desired products
59–61 in 74–80% yield.2.3. Product functionalization
The obtained building blocks contain highly interesting func-
tionalities for further modication, including in particular reac-
tive alkenes and aminals. To further establish the syntheticScheme 4 Functionalization of products 17 and 49. Reaction condi-
tions: (a) H2, Pd(OH)2 (10% w/w), CH3OH, 70%; (b) LiCl (5 equiv.),
DMSO : H2O 10 : 1, 140 C, 85%; (c) OsO4 (5 mol%), NMO$H2O (1.2
equiv.), THF : acetone : H2O (2 : 2 : 1); (d) Ac2O (3 equiv.), DMAP
(10 mol%), NEt3 (4 equiv.), CH2Cl2, 71% dr > 20 : 1 (over 2 steps); (e)
vinylMgBr (4 equiv.), ZnCl2 (10 equiv.), THF, 50 C, 68%, dr > 20 : 1; (f)
H2, Pd(OH)2 (10% w/w), CH3OH, 73%; (g) OsO4 (5 mol%), NMO$H2O
(1.2 equiv.), acetone : H2O (20 : 1), 0 C; (h) TBSOTf, pyridine, CH2Cl2,
66%, dr > 20 : 1 (over 2 steps). Phth ¼ phthalimide, TBS ¼ tert-butyl-
dimethylsilyl, NMO ¼ N-methylmorpholine-N-oxide, THF ¼ tetrahy-
drofuran, DMAP ¼ N,N-dimethylpyridin-4-amine.
Chem. Sci., 2017, 8, 7112–7118 | 7115
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View Article Onlinepotential of the method, a few transformations of the dearoma-
tization products were therefore examined (Scheme 4). Hydroge-
nation of the benzylic olen and aminal of tetrahydro-
benzoindolizine 17 and removal of one methyl ester group was
achieved using Pearlman's catalyst, followed by Krapcho decar-
boxylation to give amine 62 in 60% overall yield. The phthalimido
and the diester groups can therefore be considered as traceless
activating and directing groups for the annulation reaction.
Selective dihydroxylation of the benzylic olen from the
convex side of the molecule was possible (dr > 20 : 1). Aer
acetylation of the alcohols, the aminal was converted with high
diastereoselectivity (dr > 20 : 1) into tertiary amine 63 through
alkylation of the intermediary iminium with a vinyl zinc
reagent, resulting in the stereoselective installation of four
stereocenters around the tricyclic system.
Selective reduction of the more electron rich olen of tetra-
hydroindolizine 49 furnished compound 64 in 73% yield. More-
over, selective dihydroxylation via osmium(VIII) catalysis and
subsequent silylation of the diol gave compound 65 in high yield
and high diastereoselectivity (dr > 20 : 1). Our methodology is
therefore highly suited for accessing polysubstituted indolizidine
rings frequently encountered in natural products (Scheme 1).Scheme 5 Key experiments and speculative mechanism. aPredicted
with ACD Labs.
7116 | Chem. Sci., 2017, 8, 7112–71182.4. Speculative reaction mechanism
Three experiments gave rst insights into the reaction mecha-
nism (Scheme 5A):
(1) When pyridine (66) was reacted with cyclopropane 14
using ytterbium triate as catalyst, the desired product was not
obtained. Full conversion of cyclopropane 14 was observed, but
no pure product could be isolated from the reaction mixture.
Nevertheless, a molecular ion corresponding to zwitterion I
could be detected by mass spectroscopy.
(2) When highly electron-poor pyridine 67 was used, no
reaction was observed (eqn (2)).
(3) Quinolizine 42 could be isolated with 3.5 : 1 dr at the
diester center. However, aer separation the minor isomer 42a
equilibrated to a 1 : 1 mixture just upon standing in deuterated
chloroform (eqn (3)).
Based on these experiments and the well-established acti-
vation of DA diester cyclopropanes with Lewis acids,11a a rst
speculative mechanism can be proposed (Scheme 5B). Coordi-
nation of cyclopropane 14 by the Lewis acid led to activated
intermediate II. Only suﬃciently electron-rich pyridine (pKaH >
0.5) are nucleophilic enough to react with this intermediate and
give pyridinium III. At this point, reversible ring closure can
occur to give coordinated product IV. The equilibrium lays on
the product side for quinolines. For pyridines, this is the case
only if the heterocycle is suﬃciently electron poor (pKaH < 2.5). If
this is not the case, decoordination of the Lewis acid would free
zwitterion I,20 which could be the detected by mass spectros-
copy. The high diastereoselectivity observed in the reaction is
probably due to the higher stability of the products having the
phthalimide group in the convex face of the polycyclic systems
(thermodynamic control). From IV, the catalytic cycle is then
closed by a simple ligand exchange on ytterbium.3. Conclusion
In summary, a highly eﬃcient method for the preparation of
tetrahydroindolizine derivatives by dearomative [3 + 2] annula-
tion reactions of pyridines, isoquinolines or quinolines and
2-aminocyclopropanes was developed. The ne modulation of
the reactivity by the phthalimido group was essential for the
success of this process. Excellent yields, high diaster-
eoselectivities and a very broad substrate scope was achieved by
employing ytterbium(III) triate as catalyst. The reaction proved
to be scalable and further functionalization of the obtained
products was easily possible, setting the base for the synthesis
of more complex bioactive compounds.Conﬂicts of interest
There are no conicts to declare.Acknowledgements
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1. X-ray diffraction analysis of compound 17 
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Table S1. Crystal data and structure refinement for compound 17 
Empirical formula  C24H20N2O6 
Formula weight  432.42 
Temperature  100.01(10) K 
Wavelength  1.54184 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 28.9068(4) Å = 90°. 
 b = 7.90250(10) Å = 90°. 
 c = 8.98890(10) Å  = 90°. 
Volume 2053.39(4) Å3 
Z 4 
Density (calculated) 1.399 Mg/m3 
Absorption coefficient 0.846 mm-1 
F(000) 904 
Crystal size 0.509 x 0.409 x 0.265 mm3 
Theta range for data collection 5.797 to 75.495°. 
Index ranges -36 ≤ h ≤ 36, -9 ≤ k ≤ 9, -11 ≤ l ≤ 11 
Reflections collected 35518 
Independent reflections 4206 [Rint = 0.0326] 
Completeness to θ = 67.684° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.850 and 0.723 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4206 / 1 / 348 
Goodness-of-fit on F2 1.059 
Final R indices [I>2σ(I)] R1 = 0.0236, wR2 = 0.0639 
R indices (all data) R1 = 0.0243, wR2 = 0.0645 
Absolute structure parameter 0.01(5) 
Extinction coefficient 0.0012(2) 
Largest diff. peak and hole 0.186 and -0.133 e.Å-3 
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Table S2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
compound 17. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
O(1) 7071(1) 7430(2) 8003(1) 31(1) 
O(2) 6456(1) 9031(2) 8589(1) 28(1) 
O(3) 6155(1) 9739(2) 4455(2) 40(1) 
O(4) 6861(1) 10163(1) 5425(2) 28(1) 
O(5) 6107(1) 3180(2) 6928(1) 28(1) 
O(6) 4927(1) 5102(2) 3972(1) 29(1) 
N(1) 6306(1) 5697(2) 4369(2) 24(1) 
N(2) 5585(1) 4517(2) 5362(2) 22(1) 
C(1) 5855(1) 6043(2) 4984(2) 23(1) 
C(2) 5951(1) 7102(2) 6398(2) 25(1) 
C(3) 6453(1) 7729(2) 6229(2) 23(1) 
C(4) 6677(1) 6213(2) 5381(2) 23(1) 
C(5) 7124(1) 6551(2) 4597(2) 27(1) 
C(6) 7193(1) 6080(2) 3193(2) 27(1) 
C(7) 6828(1) 5288(2) 2309(2) 25(1) 
C(8) 6908(1) 4733(2) 862(2) 29(1) 
C(9) 6554(1) 4069(2) -1(2) 31(1) 
C(10) 6111(1) 3976(2) 596(2) 29(1) 
C(11) 6021(1) 4511(2) 2044(2) 25(1) 
C(12) 6379(1) 5161(2) 2917(2) 22(1) 
C(13) 6702(1) 8019(2) 7697(2) 24(1) 
C(14) 6674(1) 9411(2) 10007(2) 32(1) 
C(15) 6464(1) 9325(2) 5267(2) 25(1) 
C(16) 6908(1) 11653(2) 4490(2) 33(1) 
C(17) 5726(1) 3275(2) 6378(2) 23(1) 
C(18) 5320(1) 2151(2) 6596(2) 22(1) 
C(19) 5265(1) 788(2) 7539(2) 27(1) 
C(20) 4835(1) 7(2) 7551(2) 31(1) 
C(21) 4476(1) 569(2) 6646(2) 29(1) 
C(22) 4533(1) 1950(2) 5694(2) 25(1) 
C(23) 4962(1) 2725(2) 5701(2) 21(1) 
C(24) 5128(1) 4247(2) 4884(2) 23(1) 
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Table S3. Bond lengths [Å] and angles [°] for compound 17. (Symmetry transform. used to gen. equiv. atoms) 
O(1)-C(13)  1.195(2) 
O(2)-C(13)  1.339(2) 
O(2)-C(14)  1.454(2) 
O(3)-C(15)  1.199(2) 
O(4)-C(15)  1.332(2) 
O(4)-C(16)  1.453(2) 
O(5)-C(17)  1.209(2) 
O(6)-C(24)  1.211(2) 
N(1)-C(12)  1.389(2) 
N(1)-C(1)  1.442(2) 
N(1)-C(4)  1.464(2) 
N(2)-C(17)  1.401(2) 
N(2)-C(24)  1.405(2) 
N(2)-C(1)  1.476(2) 
C(1)-C(2)  1.547(2) 
C(1)-H(1)  0.94(2) 
C(2)-C(3)  1.542(2) 
C(2)-H(2A)  0.99(2) 
C(2)-H(2B)  0.98(2) 
C(3)-C(13)  1.520(2) 
C(3)-C(15)  1.529(2) 
C(3)-C(4)  1.561(2) 
C(4)-C(5)  1.496(2) 
C(4)-H(4)  1.02(2) 
C(5)-C(6)  1.331(3) 
C(5)-H(5)  1.00(2) 
C(6)-C(7)  1.462(2) 
C(6)-H(6)  1.00(2) 
C(7)-C(8)  1.392(2) 
C(7)-C(12)  1.411(2) 
C(8)-C(9)  1.387(3) 
C(8)-H(8)  0.98(2) 
C(9)-C(10)  1.391(3) 
C(9)-H(9)  0.94(3) 
C(10)-C(11)  1.393(3) 
C(10)-H(10)  0.97(2) 
C(11)-C(12)  1.396(2) 
C(11)-H(11)  0.99(2) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-C(18)  1.485(2) 
C(18)-C(19)  1.380(2) 
C(18)-C(23)  1.387(2) 
C(19)-C(20)  1.388(3) 
C(19)-H(19)  0.93(3) 
C(20)-C(21)  1.392(3) 
C(20)-H(20)  0.96(2) 
C(21)-C(22)  1.397(2) 
C(21)-H(21)  0.97(3) 
C(22)-C(23)  1.383(2) 
C(22)-H(22)  1.03(2) 
C(23)-C(24)  1.488(2) 
C(13)-O(2)-C(14) 114.64(13) 
C(15)-O(4)-C(16) 114.95(14) 
C(12)-N(1)-C(1) 123.82(14) 
C(12)-N(1)-C(4) 123.84(13) 
C(1)-N(1)-C(4) 111.78(13) 
C(17)-N(2)-C(24) 111.51(13) 
C(17)-N(2)-C(1) 124.65(13) 
C(24)-N(2)-C(1) 123.39(13) 
N(1)-C(1)-N(2) 114.27(13) 
N(1)-C(1)-C(2) 104.79(13) 
N(2)-C(1)-C(2) 110.32(13) 
N(1)-C(1)-H(1) 111.0(13) 
N(2)-C(1)-H(1) 106.2(12) 
C(2)-C(1)-H(1) 110.3(12) 
C(3)-C(2)-C(1) 105.19(13) 
C(3)-C(2)-H(2A) 113.3(13) 
C(1)-C(2)-H(2A) 109.5(14) 
C(3)-C(2)-H(2B) 108.8(13) 
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C(1)-C(2)-H(2B) 110.4(13) 
H(2A)-C(2)-H(2B) 109.5(19) 
C(13)-C(3)-C(15) 110.88(13) 
C(13)-C(3)-C(2) 114.18(14) 
C(15)-C(3)-C(2) 109.91(13) 
C(13)-C(3)-C(4) 110.10(13) 
C(15)-C(3)-C(4) 110.35(13) 
C(2)-C(3)-C(4) 101.01(12) 
N(1)-C(4)-C(5) 112.95(14) 
N(1)-C(4)-C(3) 102.39(12) 
C(5)-C(4)-C(3) 116.76(13) 
N(1)-C(4)-H(4) 109.5(11) 
C(5)-C(4)-H(4) 109.1(11) 
C(3)-C(4)-H(4) 105.7(12) 
C(6)-C(5)-C(4) 121.74(16) 
C(6)-C(5)-H(5) 123.3(12) 
C(4)-C(5)-H(5) 114.9(12) 
C(5)-C(6)-C(7) 121.79(16) 
C(5)-C(6)-H(6) 120.4(12) 
C(7)-C(6)-H(6) 117.7(12) 
C(8)-C(7)-C(12) 119.47(15) 
C(8)-C(7)-C(6) 121.55(15) 
C(12)-C(7)-C(6) 118.91(15) 
C(9)-C(8)-C(7) 121.31(17) 
C(9)-C(8)-H(8) 122.5(14) 
C(7)-C(8)-H(8) 116.1(14) 
C(8)-C(9)-C(10) 118.92(17) 
C(8)-C(9)-H(9) 120.6(15) 
C(10)-C(9)-H(9) 120.4(15) 
C(9)-C(10)-C(11) 121.00(17) 
C(9)-C(10)-H(10) 118.8(14) 
C(11)-C(10)-H(10) 120.2(14) 
C(10)-C(11)-C(12) 119.99(16) 
C(10)-C(11)-H(11) 118.2(13) 
C(12)-C(11)-H(11) 121.8(13) 
N(1)-C(12)-C(11) 121.80(15) 
N(1)-C(12)-C(7) 118.89(14) 
C(11)-C(12)-C(7) 119.31(15) 
O(1)-C(13)-O(2) 124.76(16) 
O(1)-C(13)-C(3) 124.32(15) 
O(2)-C(13)-C(3) 110.92(13) 
O(2)-C(14)-H(14A) 109.5 
O(2)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
O(2)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
O(3)-C(15)-O(4) 124.76(17) 
O(3)-C(15)-C(3) 123.63(15) 
O(4)-C(15)-C(3) 111.60(14) 
O(4)-C(16)-H(16A) 109.5 
O(4)-C(16)-H(16B) 109.5 
H(16A)-C(16)-H(16B) 109.5 
O(4)-C(16)-H(16C) 109.5 
H(16A)-C(16)-H(16C) 109.5 
H(16B)-C(16)-H(16C) 109.5 
O(5)-C(17)-N(2) 125.13(15) 
O(5)-C(17)-C(18) 128.90(15) 
N(2)-C(17)-C(18) 105.97(13) 
C(19)-C(18)-C(23) 121.71(15) 
C(19)-C(18)-C(17) 129.77(15) 
C(23)-C(18)-C(17) 108.46(14) 
C(18)-C(19)-C(20) 117.10(16) 
C(18)-C(19)-H(19) 120.5(14) 
C(20)-C(19)-H(19) 122.3(14) 
C(19)-C(20)-C(21) 121.47(17) 
C(19)-C(20)-H(20) 120.1(14) 
C(21)-C(20)-H(20) 118.4(14) 
C(20)-C(21)-C(22) 121.19(16) 
C(20)-C(21)-H(21) 118.9(15) 
C(22)-C(21)-H(21) 119.9(15) 
C(23)-C(22)-C(21) 116.76(15) 
C(23)-C(22)-H(22) 125.1(13) 
C(21)-C(22)-H(22) 118.1(13) 
C(22)-C(23)-C(18) 121.76(15) 
C(22)-C(23)-C(24) 130.10(15) 
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C(18)-C(23)-C(24) 108.10(13) 
O(6)-C(24)-N(2) 125.05(15) 
O(6)-C(24)-C(23) 129.02(15) 
N(2)-C(24)-C(23) 105.92(13) 
 
Table S4. Anisotropic displacement parameters (Å2x 103)for compound 17.  
The anisotropic displacement factor exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 U11 U22 U33 U23 U13 U12 
O(1) 29(1)  36(1) 29(1)  -2(1) -5(1)  5(1) 
O(2) 28(1)  31(1) 27(1)  -5(1) 0(1)  1(1) 
O(3) 38(1)  38(1) 43(1)  12(1) -17(1)  -7(1) 
O(4) 24(1)  24(1) 35(1)  5(1) 0(1)  -2(1) 
O(5) 24(1)  33(1) 27(1)  1(1) -6(1)  1(1) 
O(6) 23(1)  33(1) 32(1)  10(1) -4(1)  0(1) 
N(1) 20(1)  29(1) 24(1)  -4(1) 0(1)  -3(1) 
N(2) 21(1)  23(1) 24(1)  1(1) -1(1)  -2(1) 
C(1) 22(1)  22(1) 25(1)  1(1) 1(1)  -2(1) 
C(2) 23(1)  24(1) 29(1)  -4(1) 2(1)  -2(1) 
C(3) 22(1)  23(1) 24(1)  -1(1) -1(1)  -1(1) 
C(4) 23(1)  22(1) 25(1)  -2(1) -2(1)  -1(1) 
C(5) 21(1)  27(1) 32(1)  -3(1) 0(1)  0(1) 
C(6) 22(1)  27(1) 31(1)  0(1) 2(1)  0(1) 
C(7) 26(1)  22(1) 25(1)  3(1) 1(1)  2(1) 
C(8) 28(1)  30(1) 28(1)  2(1) 3(1)  3(1) 
C(9) 35(1)  34(1) 23(1)  -2(1) -2(1)  5(1) 
C(10) 31(1)  30(1) 26(1)  -1(1) -5(1)  1(1) 
C(11) 26(1)  25(1) 26(1)  1(1) -2(1)  1(1) 
C(12) 26(1)  19(1) 23(1)  3(1) -1(1)  2(1) 
C(13) 26(1)  21(1) 25(1)  0(1) 0(1)  -3(1) 
C(14) 33(1)  37(1) 27(1)  -8(1) 0(1)  -4(1) 
C(15) 25(1)  24(1) 26(1)  -1(1) -1(1)  0(1) 
C(16) 33(1)  27(1) 39(1)  8(1) 5(1)  0(1) 
C(17) 25(1)  24(1) 20(1)  -1(1) 0(1)  1(1) 
C(18) 24(1)  22(1) 20(1)  -3(1) 1(1)  1(1) 
C(19) 31(1)  26(1) 24(1)  2(1) -1(1)  2(1) 
C(20) 36(1)  28(1) 29(1)  7(1) 4(1)  -1(1) 
C(21) 29(1)  29(1) 30(1)  2(1) 2(1)  -6(1) 
C(22) 24(1)  27(1) 23(1)  -1(1) 0(1)  -2(1) 
C(23) 23(1)  23(1) 19(1)  -2(1) 2(1)  1(1) 
C(24) 23(1)  23(1) 22(1)  -1(1) 1(1)  1(1) 
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Table S5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for compound 17. 
 x  y  z  U(eq) 
H(1) 5672(7) 6660(30) 4310(20) 23(5) 
H(2A) 5722(8) 8030(30) 6470(30) 35(6) 
H(2B) 5930(7) 6390(30) 7280(30) 33(6) 
H(4) 6727(7) 5290(20) 6160(20) 21(5) 
H(5) 7368(7) 7090(30) 5220(30) 30(5) 
H(6) 7496(7) 6310(20) 2690(20) 25(5) 
H(8) 7224(8) 4870(30) 490(30) 34(6) 
H(9) 6615(8) 3650(30) -960(30) 41(6) 
H(10) 5861(8) 3540(30) -20(30) 36(6) 
H(11) 5700(7) 4440(30) 2410(20) 27(5) 
H(14A) 7006 9584 9856 49 
H(14B) 6626 8464 10694 49 
H(14C) 6537 10440 10426 49 
H(16A) 6898 11316 3441 49 
H(16B) 7203 12211 4701 49 
H(16C) 6653 12438 4697 49 
H(19) 5510(8) 410(30) 8130(30) 34(6) 
H(20) 4780(8) -950(30) 8190(30) 33(6) 
H(21) 4180(9) -10(30) 6690(30) 42(6) 
H(22) 4252(7) 2360(30) 5090(30) 30(5) 
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Table S6. Torsion angles [°] for compound 17. 
C(12)-N(1)-C(1)-N(2) 76.2(2) 
C(4)-N(1)-C(1)-N(2) -112.13(15) 
C(12)-N(1)-C(1)-C(2) -162.91(15) 
C(4)-N(1)-C(1)-C(2) 8.74(17) 
C(17)-N(2)-C(1)-N(1) 59.5(2) 
C(24)-N(2)-C(1)-N(1) -128.82(16) 
C(17)-N(2)-C(1)-C(2) -58.23(19) 
C(24)-N(2)-C(1)-C(2) 113.43(16) 
N(1)-C(1)-C(2)-C(3) 16.44(17) 
N(2)-C(1)-C(2)-C(3) 139.89(14) 
C(1)-C(2)-C(3)-C(13) -151.30(13) 
C(1)-C(2)-C(3)-C(15) 83.38(16) 
C(1)-C(2)-C(3)-C(4) -33.19(16) 
C(12)-N(1)-C(4)-C(5) 15.4(2) 
C(1)-N(1)-C(4)-C(5) -156.26(14) 
C(12)-N(1)-C(4)-C(3) 141.81(15) 
C(1)-N(1)-C(4)-C(3) -29.84(17) 
C(13)-C(3)-C(4)-N(1) 158.69(13) 
C(15)-C(3)-C(4)-N(1) -78.59(15) 
C(2)-C(3)-C(4)-N(1) 37.66(16) 
C(13)-C(3)-C(4)-C(5) -77.40(18) 
C(15)-C(3)-C(4)-C(5) 45.33(19) 
C(2)-C(3)-C(4)-C(5) 161.57(15) 
N(1)-C(4)-C(5)-C(6) -13.2(2) 
C(3)-C(4)-C(5)-C(6) -131.54(17) 
C(4)-C(5)-C(6)-C(7) 3.4(3) 
C(5)-C(6)-C(7)-C(8) -177.23(16) 
C(5)-C(6)-C(7)-C(12) 5.9(2) 
C(12)-C(7)-C(8)-C(9) 0.6(2) 
C(6)-C(7)-C(8)-C(9) -176.30(17) 
C(7)-C(8)-C(9)-C(10) 0.6(3) 
C(8)-C(9)-C(10)-C(11) -1.1(3) 
C(9)-C(10)-C(11)-C(12) 0.4(3) 
C(1)-N(1)-C(12)-C(11) -16.3(2) 
C(4)-N(1)-C(12)-C(11) 173.04(15) 
C(1)-N(1)-C(12)-C(7) 163.36(14) 
C(4)-N(1)-C(12)-C(7) -7.3(2) 
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C(10)-C(11)-C(12)-N(1) -179.55(15) 
C(10)-C(11)-C(12)-C(7) 0.8(2) 
C(8)-C(7)-C(12)-N(1) 179.08(15) 
C(6)-C(7)-C(12)-N(1) -4.0(2) 
C(8)-C(7)-C(12)-C(11) -1.3(2) 
C(6)-C(7)-C(12)-C(11) 175.71(15) 
C(14)-O(2)-C(13)-O(1) 1.0(2) 
C(14)-O(2)-C(13)-C(3) -178.56(13) 
C(15)-C(3)-C(13)-O(1) -107.51(18) 
C(2)-C(3)-C(13)-O(1) 127.69(18) 
C(4)-C(3)-C(13)-O(1) 14.9(2) 
C(15)-C(3)-C(13)-O(2) 72.02(16) 
C(2)-C(3)-C(13)-O(2) -52.78(18) 
C(4)-C(3)-C(13)-O(2) -165.57(13) 
C(16)-O(4)-C(15)-O(3) -1.6(3) 
C(16)-O(4)-C(15)-C(3) 177.12(14) 
C(13)-C(3)-C(15)-O(3) -145.69(18) 
C(2)-C(3)-C(15)-O(3) -18.5(2) 
C(4)-C(3)-C(15)-O(3) 92.0(2) 
C(13)-C(3)-C(15)-O(4) 35.57(19) 
C(2)-C(3)-C(15)-O(4) 162.76(14) 
C(4)-C(3)-C(15)-O(4) -86.69(17) 
C(24)-N(2)-C(17)-O(5) 177.73(15) 
C(1)-N(2)-C(17)-O(5) -9.8(3) 
C(24)-N(2)-C(17)-C(18) -1.79(17) 
C(1)-N(2)-C(17)-C(18) 170.73(14) 
O(5)-C(17)-C(18)-C(19) 4.4(3) 
N(2)-C(17)-C(18)-C(19) -176.13(16) 
O(5)-C(17)-C(18)-C(23) -178.23(16) 
N(2)-C(17)-C(18)-C(23) 1.26(17) 
C(23)-C(18)-C(19)-C(20) 0.3(3) 
C(17)-C(18)-C(19)-C(20) 177.37(17) 
C(18)-C(19)-C(20)-C(21) 0.2(3) 
C(19)-C(20)-C(21)-C(22) -0.3(3) 
C(20)-C(21)-C(22)-C(23) -0.1(3) 
C(21)-C(22)-C(23)-C(18) 0.7(2) 
C(21)-C(22)-C(23)-C(24) -176.95(16) 
C(19)-C(18)-C(23)-C(22) -0.8(2) 
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C(17)-C(18)-C(23)-C(22) -178.39(15) 
C(19)-C(18)-C(23)-C(24) 177.33(15) 
C(17)-C(18)-C(23)-C(24) -0.32(17) 
C(17)-N(2)-C(24)-O(6) -177.52(16) 
C(1)-N(2)-C(24)-O(6) 9.9(3) 
C(17)-N(2)-C(24)-C(23) 1.60(17) 
C(1)-N(2)-C(24)-C(23) -171.03(14) 
C(22)-C(23)-C(24)-O(6) -3.8(3) 
C(18)-C(23)-C(24)-O(6) 178.32(17) 
C(22)-C(23)-C(24)-N(2) 177.12(16) 
C(18)-C(23)-C(24)-N(2) -0.74(17) 
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2. General methods 
 
All reactions were carried out in oven- or flame dried glassware under nitrogen atmosphere, unless 
stated otherwise. For quantitative flash chromatography, distilled technical grade solvents were used. 
THF, Et2O, CH3CN and CH2Cl2 were dried by passage over activated alumina under nitrogen atmosphere 
(H2O content < 7 ppm, Karl-Fischer titration). NEt3 was dried by distillation over CaH2 under nitrogen 
atmosphere. All chemicals were purchased and used as received unless stated otherwise. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel silica 40-
63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was performed on Merck 
silica gel 60 F254 TLC aluminium plates and visualized with UV-light, permanganate, CAM or 
p-anisaldehyde stains. 1H-NMR spectra were recorded at room temperature on a Brucker DPX-400 
400 MHz spectrometer in chloroform-d or D6-DMSO; all signals are reported in ppm with the internal 
chloroform signal at 7.26 ppm or the internal D6-DMSO signal at 2.50 ppm as standard. The data is 
being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or 
unresolved, br = broad signal, integration, coupling constant(s) in Hz, interpretation). 13C-NMR spectra 
were recorded with 1H-decoupling on a Bruker DPX-400 101 MHz spectrometer in chloroform-d or D6-
DMSO; all signals are reported in ppm with the internal chloroform signal at 77.00 ppm or the internal 
DMSO signal at 39.51 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 
spectrophotometer with an ATR PRO4100-S and a ZnSe prism and are reported as cm-1 (w = weak, m 
= medium, s = strong). High resolution mass spectrometric measurements were performed by the mass 
spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. Melting points were 
measured on a Buechi B-540 melting point apparatus and were not corrected. 
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3. Synthesis of diazo compounds 
 
Dimethyl 2-diazomalonate (SI-2). 
 
Following a modified procedure,1 triethylamine (9.23 mL, 66.6 mmol, 2.4 equiv.) and dimethyl 
malonate SI-1 (3.19 mL, 27.8 mmol, 1 equiv.) were added to a solution of pABSA (10.0 g, 41.6 mmol, 
1.5 equiv.) in CH3CN (111 mL, 0.25 M) at room temperature and the resulting mixture was stirred for 
18 hours at room temperature. Thereafter the mixture was filtered and the solvent was evaporated. 
The residue was triturated with CH2Cl2 (50 mL), the remaining solids were filtered off and the solvent 
was evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 10:1 to 
5:1) and 4.28 g (27.1 mmol, 98%) of the title compound SI-2 were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 3.84 (s, 6H, CH3). 
1H-NMR data match the literature report.1 
 
Dibenzyl 2-diazomalonate (SI-4). 
 
Following a modified procedure,2 triethylamine (1.33 mL, 9.60 mmol, 2.4 equiv.) and dibenzyl 
malonate SI-3 (1.00 mL, 4.00 mmol, 1 equiv.) were added to a solution of pABSA (1.44 g, 6.00 mmol, 
1.5 equiv.) in CH3CN (16.0 mL, 0.25 M) at room temperature and the resulting mixture was stirred for 
18 hours at room temperature. Thereafter the mixture was filtered and the solvent was evaporated. 
The residue was triturated with CH2Cl2 (20 mL), the remaining solids were filtered off and the solvent 
was evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 10:1) and 
1.19 g (3.83 mmol, 96%) of the title compound SI-4 were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 7.42 – 7.28 (m, 10H, ArH), 5.28 (s, 4H, CH2). 
1H-NMR data match the literature report.1 
                                                          
1 F. de Nanteuil, J. Waser, Angew. Chem. Int. Ed.,2011, 50, 12075–12079. 
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Bis(2,2,2-trifluoroethyl) malonate (SI-7). 
 
Following a modified procedure,2 H2SO4 (1.00 mL, 18.8 mmol, 0.25 equiv.) was added to a solution of 
trifluoroethanol SI-5 (29.9 mL, 415 mmol, 5.4 equiv.) and malonic acid SI-6 (8.00 g, 77.0 mmol, 
1 equiv.) in toluene (40.0 mL, 1.9 M) and the resulting mixture was heated to reflux for 8 hours. After 
cooling to room temperature, toluene (80.0 mL) was added and the mixture was washed with aq. 
NaOH (200 mL, 1 M), water (200 mL) and brine (200 mL). The organic layer was dried over MgSO4 and 
the solvent was evaporated which afforded 6.80 g (25.4 mmol, 33%) of the title compound SI-7 as a 
colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 4.55 (q, J = 8.2 Hz, 4H, OCH2), 3.61 (s, 2H, CH2). 
1H-NMR data match the literature report.2 
 
Bis(2,2,2-trifluoroethyl) 2-diazomalonate (SI-8). 
 
Following a modified procedure,2 triethylamine (6.00 mL, 43.3 mmol, 2.4 equiv.) and 
bis(trifluorethyl)malonate SI-7 (4.84 g, 18.0 mmol, 1 equiv.) were added to a solution of pABSA (6.50 g, 
27.1 mmol, 1.5 equiv.) in CH3CN (72.0 mL, 0.25 M) at room temperature and the resulting mixture was 
stirred for 18 hours at room temperature. Thereafter the mixture was filtered and the solvent was 
evaporated. The residue was triturated with CH2Cl2 (50 mL), the solids were filtered off and the solvent 
was evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 10:1 to 
5:1) and 5.26 g (17.9 mmol, 99%) of the title compound SI-8 were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 4.63 (q, J = 8.2 Hz, 4H, OCH2). 
1H-NMR data match the literature report.2 
  
                                                          
2 F. de Nanteuil, J. Loup, and J. Waser Org. Lett. 2013, 15, 3738-3741. 
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1-tert-Butyl 3-methyl 2-diazomalonate (SI-10). 
 
Following a modified procedure,3 triethylamine (1.97 mL, 14.2 mmol, 2.4 equiv.) and tert-butyl methyl 
malonate SI-9 (1.00 mL, 5.91 mmol, 1 equiv.) were added to a solution of pABSA (2.13 g, 8.87 mmol, 
1.5 equiv.) in CH3CN (23 mL, 0.25 M) at room temperature and the resulting mixture was stirred for 
18 hours at room temperature. Thereafter the mixture was filtered and the solvent was evaporated. 
The residue was triturated with CH2Cl2 (25 mL), the remaining solids were filtered and the solvent was 
evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 20:1 to 10:1) 
and 1.05 g (5.24 mmol, 89%) of the title compound SI-10 were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 3.82 (s, 3H, CH3), 1.50 (s, 9H, C(CH3)3). 
HRMS (ESI) calcd. for C8H13N2O4+ [M+H]+ 201.0870; found 201.0690. 
1H-NMR data match the literature report.3 
 
4. Synthesis of aminocyclopropanes 
 
Bimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (14). 
 
Following a modified procedure,1 a solution of dimethyldiazomalonate SI-2 (2.21 g, 14.0 mmol, 
1.1 equiv.) in CH2Cl2 (10.0 mL) was added over 5 minutes at 0 °C to a solution of Rh2(esp)2 (19.0 mg, 
25.0 µmol, 0.2 mol%) and N-vinyl-phtalimide SI-11 (2.20 g, 12.7 mmol, 1 equiv.) in CH2Cl2 (40 mL). The 
reaction mixture was stirred for 16 hours while warming to room temperature. Thereafter the solvent 
was evaporated and the residue was purified by column chromatography (silica, pentane:EtOAc 10:1 
to pentane:EtOAc 4:1) affording 3.23 g (10.7 mmol, 84%) of the title compound 14 as a colorless oil. 
                                                          
3 F. de Simone, T. Saget, F. Benfatti, S. Almeida, J. Waser Chem. Eur. J. 2011, 17, 14527-14538. 
16 
 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
3.83 (s, 3H, OCH3), 3.70 (dd, J = 8.5, 6.6 Hz, 1H, CH-Phth), 3.62 (s, 3H, OCH3), 2.71 (t, J = 6.6 Hz, 1H, CH2), 
2.04 (dd, J = 8.5, 6.6 Hz, 1H, CH2). 
1H-NMR data match the literature report.1 
 
5,6-Dichloro-2-vinylisoindoline-1,3-dione (SI-14). 
 
Following a modified procedure,7 Na2PdCl4 (27.0 mg, 92 µmol, 2 mol%) was added to a stirred solution 
of 4,5-dichlorophthalimide (SI-13) (1.00 g, 4.63 mmol, 1.00 equiv.) in vinyl acetate (SI-12) (11.5 mL, 
124 mmol, 26.8 equiv.), and the mixture was heated under reflux for 48 h. After solvent evaporation, 
the crude was purified by Biotage (SNAP Cartridge KP-Sil 25 g, 8:2 Hexane/EtOAc) to obtain 1.25 g 
(4.63 mmol, 46%) of the title compound SI-14 as a yellow solid.  
1H NMR (400 MHz, CDCl3) δ = 7.96 (s, 2H, ArH), 6.84 (dd, J = 16.4, 9.8 Hz, 1H, N-CH), 6.09 (dd, J = 16.4, 
0.3 Hz, 1H, =CH), 5.10 (dd, J = 9.8, 0.3 Hz, 1H, =CH). 
1H-NMR data match the literature report.7 
 
Dimethyl 2-(5,6-dichloro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-15). 
 
Following a modified procedure,8 a solution of dimethyl diazomalonate (SI-2) (0.51 mL, 4.40 mmol, 
1.5 equiv.) in CH2Cl2 (8.0 mL) was added dropwise over 5 minutes to a solution of 5,6-dichloro-2-
vinylisoindoline- 1,3-dione (SI-14) (72.0 mg, 3.00 mmol, 1 equiv.) and Rh2(esp)2 (4.50 mg, 5.90 μmol, 
0.2 mol%) in CH2Cl2 (4.0 mL) at 0 °C. After stirring the resulting mixture overnight at room temperature, 
the solution was concentrated under reduced pressure. Purification by Biotage (SNAP cartridge KP-Sil 
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25 g, hexane:EtOAc 95:5 to 6:4) afforded 810 mg (2.20 mmol, 74%) of the title compound SI-15 as a 
colorless solid. 
1H NMR (400 MHz, CDCl3) δ = 7.92 (s, 2H, ArH), 3.82 (s, 3H, OCH3), 3.66 (dd, J = 8.5, 6.5 Hz, 1H, CH-
Phth), 3.63 (s, 3H, OCH3), 2.64 (dd, J = 6.5. 6.5 Hz, 1H, CH2), 2.07-2.01 (m, 1H, CH2). 
1H-NMR data match the literature report.8 
 
5-Nitro-2-vinylisoindoline-1,3-dione (SI-17). 
 
Following a modified procedure,4 PdCl2 (92 mg, 0.52 mmol, 10 mol%) and LiCl (221 mg, 5.20 mmol, 
1 equiv.) were added to a solution of 5-nitrosoindoline-1,3-dione (SI-16) (1.00 g, 5.20 mmol, 1 equiv.) 
in vinyl acetate (SI-12) (12.9 mL, 139 mmol, 27 equiv.) and the mixture was heated to reflux for 
20 hours. After cooling to room temperature the solvent was evaporated and the residue was purified 
by column chromatography (hexane:EtOAc 4:1 to 1:1) affording 1.14 g (5.23 mmol, quant.) of the title 
compound SI-17 as a bright yellow solid. 
1H NMR (400 MHz, CDCl3) δ = 8.68 (dd, J = 2.0, 0.5 Hz, 1H, ArH), 8.63 (dd, J = 8.1, 2.0 Hz, 1H, ArH), 8.08 
(m, 1H, ArH), 6.88 (dd, J = 16.4, 9.8 Hz, 1H, CH-N), 6.14 (dd, J = 16.4, 0.5 Hz, 1H, =CH2), 5.16 (dd, J = 9.8, 
0.5 Hz, 1H, =CH2) ppm. 
1H-NMR data match the literature report.4 
 
Dimethyl 2-(5-nitro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-18). 
 
Following a modified procedure,4 a solution of dimethyldiazomalonate (SI-2) (0.12 g 0.77 mmol, 
1.2 equiv.) in CH2Cl2 (1.0 mL) was added over 5 minutes to a solution of 5-nitro-2-vinylisoindoline-1,3-
                                                          
4 F. de Nanteuil, E. Serrano, D. Perrotta, and J. Waser J. Am. Chem. Soc. 2014 136, 6239-6242. 
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dione (SI-17) (0.13 g, 0.64 mmol, 1 equiv.) and Rh2(esp)2 (1 mg, 1.2 µmol, 0.2 mol%) in CH2Cl2 (1.6 mL) 
at 0 °C and the resulting mixture was stirred for 16 hours while warming to room temperature. 
Thereafter the solvent was evaporated and the residue was purified by column chromatography (silica, 
hexane:EtOAc 6:4) affording 0.18 g (0.53 mmol, 83%) of the title compound SI-18 as a colorless solid. 
1H NMR (400 MHz, CDCl3) δ = 8.61 (m, 2H, ArH), 8.03 (d, J = 8.1 Hz, 1H, ArH), 3.83 (s, 3H, OCH3), 3.70 
(m, 1H, CH-N), 3.62 (s, 3H, OCH3), 2.63 (m, 1H, CH2), 2.07 (m, 1H, CH2). 
1H-NMR data match the literature report.4 
 
1-Vinyl-1H-pyrrole-2,5-dione (SI-20). 
 
Following a modified procedure,7 maleimide (SI-19) (1.30 g, 13.4 mmol, 1 equiv.), palladium(II) chloride 
(240 mg, 1.34 mmol, 0.1 equiv.), lithium chloride (57.0 mg, 1.34 mmol, 0.1 equiv.) and vinyl acetate 
(SI-12) (33.2 mL, 359 mmol, 27 equiv.) were added in a microwave tube sealed with a microwave cap. 
After stirring at 80 °C for 23 h, the resulting mixture was cooled down to room temperature. 
Purification by Biotage (SNAP cartridge KP-Sil 50 g, hexane:EtOAc 93:7 to 40:60) afforded 1.74 g 
(14.1 mmol, quant.) of the title compound SI-20 as a bright yellow oil.  
1H NMR (400 MHz, CDCl3) δ = 6.74 (s, 2H, CH-C=O), 6.67 (dd, J = 16.4, 9.8 Hz, 1H, CH-N), 5.87 (d, J = 
16.4 Hz, 1H, =CH2), 4.94 (d, J = 9.8 Hz, 1H, =CH2). 
1H-NMR data match the literature report.7 
 
Dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclopropane-1,1-dicarboxylate (SI-21). 
 
Following a modified procedure,8 a solution of dimethyl diazomalonate (SI-2) (96 mg, 0.61 mmol, 
1.5 equiv.) in CH2Cl2 (1.0 mL) was added dropwise over 5 minutes to a solution of 1-vinyl-1H-pyrrole-
2,5-dione (SI-20) (50 mg, 0.41 mmol, 1 equiv.) and Rh2(esp)2 (0.7 mg, 0.9 μmol, 0.2 mol%) in CH2Cl2 
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(2.0 mL) at 0 °C. The resulting mixture was stirred for 5 hours at room temperature and thereafter 
concentrated under reduced pressure. Purification by Biotage (SNAP cartridge KP-Sil 10 g, 
hexane/EtOAc 95:5 to 70:30) afforded 66.9 mg (0.264 mmol, 65%) of the title compound SI-21 as a 
colorless oil.  
1H NMR (400 MHz, CDCl3) δ = 6.67 (s, 2H, CH-C=O), 3.79 (s, 3H, OCH3), 3.66 (s, 3H, OCH3), 3.56-3.51 (m, 
1H, CH-N), 2.56 (dd, J = 6.4, 6.5 Hz, 1H, CH2), 1.96-1.91 (m, 1H, CH2) ppm. 
1H-NMR data match the literature report.8 
 
1-Vinylpyrrolidine-2,5-dione (SI-23). 
 
Following a modified procedure,5 succinimide (SI-22) (1.00 g, 10.1 mmol, 1.00 equiv.), vinyl acetate (SI-
12) (25.0 mL, 270 mmol, 26.8 eq) and Na2PdCl4 (59.0 mg, 0.202 mmol, 2.00 mol%) were heated under 
reflux for 72 hours. After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-
Sil 50 g, 7:3 Hexane/EtOAc) to obtain the title compound SI-23 (1.22 g, 9.78 mmol, 97%) as a yellow 
solid. 
1H NMR (400 MHz, CDCl3) δ = 6.68 (dd, J = 16.4, 9.9 Hz, 1H, N-CH), 6.08 (d, J = 16.4 Hz, 1H, =CH), 5.06 
(d, J = 9.9 Hz, 1H, =CH), 2.72 (s, 4H, CH2) ppm. 
1H-NMR data match the literature report.5 
 
Dimethyl 2-(2,5-dioxopyrrolidin-1-yl)cyclopropane-1,1-dicarboxylate (SI-24). 
 
Following a modified procedure,4 a solution of dimethyldiazomalonate (SI-2) (300 mg, 4.80 mmol, 
1.2 equiv.) in CH2Cl2 (4 mL) was added over 5 minutes to a solution of N-vinyl-succinimide (SI-23) 
(500 mg, 4.00 mmol, 1.00 equiv.), and Rh2(esp)2 (3.0 mg, 4.0 μmol, 0.10 mol%) in CH2Cl2 (15 mL) at 0 °C 
                                                          
5 E. Bayer, K. Geckeler, Angew. Chem. Int. Ed. 1979, 18, 533. 
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and the mixture was warmed to room temperature over 16 hours. Thereafter the solvent was 
evaporated and the residue was purified by Biotage (SNAP Cartridge KP-Sil 50 g, 1:1 hexane/EtOAc) 
affording the title compound SI-24 as a yellow solid (801 mg, 3.14 mmol, 79%). 
1H NMR (400 MHz, CDCl3) δ = 3.78 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 3.45 (dd, J = 8.5, 6.5 Hz, 1H, N-CH), 
2.73-2.58 (m, 4H, O=C-CH2), 2.45 (dd, J = 6.5, 6.5 Hz, 1H, CH2), 1.93 (dd, J = 8.5, 6.5 Hz, 1H, CH2) ppm. 
1H-NMR data match the literature report.4 
 
1H-Benzo[f]isoindole-1,3(2H)-dione (SI-27). 
 
Following a modified procedure,6 naphtho[2,3-c]furan-1,3-dione (SI-25) (500 mg, 2.52 mmol, 1 equiv.) 
and formamide SI-26 (10.0 mL, 252 mmol, 100 equiv.) were added in a 20 mL microwave vial and 
sealed with a microwave cap. The mixture was stirred until the product was completely dissolved. The 
mixture was heated twice at 200 °C for 30 sec with 10 sec pre-stirring, using Biotage Initiator 2.0 
microwave reactor. The mixture was cooled to 0 °C and cold water (10 mL) was added into the tube. 
The solid was filtrated over a filter paper, washed with water (15 mL) and hexane (20 mL) and dried 
under reduced pressure to afford 432 mg (2.19 mmol, 87%) of the title compound SI-27 as a beige solid 
which was used without further purification.  
1H NMR (400 MHz, [D6]-DMSO) δ = 11.5 (s, 1H, NH), 8.45 (s, 2H, ArH), 8.26 (dd, J = 6.6, 3.3 Hz, 2H, ArH), 
7.76 (dd, J = 6.6, 3.3 Hz, 2H, ArH). 
1H-NMR data match the literature report.6 
  
                                                          
6 K. Kacprzak, Synth. Commun. 2003, 33, 1499-1507. 
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2-Vinyl-1H-benzo[f]isoindole-1,3(2H)-dione (SI-28). 
 
Following a modified procedure,7 1H-benzo[f]isoindole-1,3(2H)-dione (SI-27) (1.70 g, 8.62 mmol, 
1 equiv.), palladium(II) chloride (0.15 g, 0.86 mmol, 0.1 equiv.), lithium chloride (40 mg, 0.86 mmol, 
0.1 equiv.) and vinyl acetate (SI-12) (21.4 mL, 231 mmol, 27 equiv.) were added in a microwave tube 
sealed with a microwave cap. After stirring for 31 h at 80 °C, the resulting mixture was cooled down to 
room temperature. Purification by silica gel chromatography (hexane:EtOAc 17:1 to 10:1) afforded 
1.26 g (5.66 mmol, 66%) the title compound SI-28 as a colorless solid. 
1H NMR (400 MHz, CDCl3) δ = 8.37 (s, 2H, ArH), 8.07 (dd, J = 6.3, 3.4 Hz, 2H, ArH), 7.72 (dd, J = 6.3, 3.4 
Hz, 2H, ArH), 6.97 (dd, J = 16.4, 9.8 Hz, 1H, Phth-CH), 6.20 (d, J = 16.4 Hz, 1H, =CH), 5.12 (d, J = 9.8 Hz, 
1H, =CH). 
1H-NMR data match the literature report.7 
 
Dimethyl 2-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-yl)cyclopropane-1,1-dicarboxylate (SI-29). 
 
Following a modified procedure,8 a solution of dimethyl 2-diazomalonate (SI-2) (20 mg, 1.30 mmol, 
1.5 equiv.) in dichloromethane (2.00 mL) was added dropwise over 5 minutes to a solution of 2-vinyl-
1H-benzo[f]isoindole- 1,3(2H)-dione (SI-28) (0.19 g, 0.85 mmol, 1 equiv.) and Rh2(esp)2 (1 mg, 
1.70 μmol, 0.2 mol%) in CH2Cl2 (3.00 mL) at 0 °C. After stirring the resulting mixture for 26 hours at 
room temperature the solution was concentrated under reduced pressure. Purification by silica gel 
chromatography (hexane:EtOAc 8:2 to 6:4) afforded 0.28 g (0.80 mmol, 94%) the title compound SI-29 
as a colorless solid. 
                                                          
7 N. Baret, J.-P. Dulcere, J. Rodriguez, J.-M. Pons, R. Faure, Eur. J. Org. Chem. 2000, 1507-1516. 
8 F. Gonzalez-Bobes, M. D. B. Fenster, S. Kiau, L. Kolla, S. Kolotuchin, M. Soumeillant, Adv. Synth. Catal. 2008, 350, 813. 
22 
 
1H NMR (400 MHz, CDCl3) δ = 8.34 (s, 2H, ArH), 8.06 (dd, J = 6.2, 3.3 Hz, 2H, ArH), 7.70 (dd, J = 6.2, 3.3 
Hz, 2H, ArH), 3.84 (s, 3H, OCH3), 3.77 (dd, J = 8.5, 6.5 Hz, 1H CH-N), 3.60 (s, 3H, OCH3), 2.78 (dd, J = 6.5, 
6.5 Hz, 1H, CH2), 2.08 (dd, J = 8.5, 6.5, 1H, CH2). 
1H-NMR data match the literature report.8 
 
Dibenzyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-30). 
 
Following a modified procedure,2 a solution of dibenzyl diazomalonate SI-4 (1.19 g, 3.83 mmol, 
1.1 equiv.) in CH2Cl2 (5 mL) was added over 5 minutes at 0 °C to a solution of Rh2(esp)2 (6 mg, 7 µmol, 
0.2 mol%) and N-vinyl-phtalimide (SI-11) (604 mg, 3.49 mmol, 1 equiv.) in CH2Cl2 (9 mL). The reaction 
mixture was stirred for 16 hours while warming to room temperature. Thereafter the solvent was 
evaporated and the residue was purified by column chromatography (silica, pentane:EtOAc 10:1 to 
pentane:EtOAc 4:1) affording 625 mg (1.37 mmol, 39%) of the title compound SI-30 as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.76 (dd, J = 5.5, 3.2 Hz, 2H, Phth), 7.73 – 7.66 (m, 2H, Phth), 7.35 – 7.30 
(m, 5H, ArH), 7.23 – 7.12 (m, 5H, ArH), 5.29 – 5.17 (m, 2H, CH2Ph), 5.04 – 4.95 (m, 2H, CH2Ph), 3.78 – 
3.70 (m, 1H, CH-Phth), 2.79 (dd, J = 6.5, 6.5 Hz, 1H, CH2), 2.05 (dd, J = 8.5, 6.5 Hz, 1H, CH2). 
1H-NMR data match the literature report.2 
 
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-31). 
 
Following a modified procedure,2 a solution of bis(trifluoroethyl)diazomalonate SI-8 (5.26 g, 
17.9 mmol, 1.1 equiv.) in CH2Cl2 (13 mL) was added over 5 minutes at 0 °C to a solution of Rh2(esp)2 
(25 mg, 33 µmol, 0.2 mol%) and N-vinyl-phtalimide (SI-11) (2.82 g, 16.3 mmol, 1 equiv.) in CH2Cl2 
(30 mL). The reaction mixture was stirred for 16 hours while warming to room temperature. Thereafter 
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the solvent was evaporated and the residue was purified by column chromatography (silica, 
pentane:EtOAc 10:1 to pentane:EtOAc 7:3) affording 5.18 g (11.8 mmol, 73%) of the title compound 
SI-31 as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.75 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
4.62 (q, J = 8.2 Hz, 2H, CH2CF3), 4.53 – 4.26 (m, 2H, CH2CF3), 3.84 (dd, J = 8.5, 6.9 Hz, 1H, CH-Phth), 2.91 
(dd, J = 6.9, 6.9 Hz, 1H, CH2), 2.20 (dd, J = 8.5, 6.9 Hz, 1H, CH2). 
1H-NMR data match the literature report.2 
 
1-tert-Butyl 1-methyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-32). 
 
A solution of tert-butyl methyl diazomalonate (SI-10) (1.05 g, 5.24 mmol, 1.1 equiv.) in CH2Cl2 (5 mL) 
was added over 5 minutes at 0 °C to a solution of Rh2(esp)2 (7.2 mg, 9.5 µmol, 0.2 mol%) and N-vinyl-
phtalimide (SI-11) (826 mg, 4.77 mmol, 1 equiv.) in CH2Cl2 (12 mL). The reaction mixture was stirred 
for 16 hours while warming to room temperature. Thereafter the solvent was evaporated and the 
residue was purified by column chromatography (silica, pentane:EtOAc 10:1 to pentane:EtOAc 4:1) 
affording 1.26 g (3.65 mmol, 77%) of the title compound (SI-32) as a colorless oil.9 
Rf: 0.5 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.77 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.67 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.61 – 6.52 (m, 1H, CH-Phth), 3.56 (s, 3H, OCH3), 2.57 (dd, J = 6.4, 6.4 Hz, 1H, CH2), 1.89 (dd, J = 8.5, 6.4 
Hz, 1H, CH2), 1.45 (s, 9H, C(CH3)3); 
13C NMR (101 MHz, CDCl3): δ = 167.9, 167.4, 166.9, 134.3, 131.4, 123.4, 82.5, 52.7, 34.3, 34.2, 27.9, 
19.0 ppm; 
IR (film): ?̃? = 2349 (w), 2139 (w), 1777 (m), 1764 (m), 1724 (s), 1438 (w), 1393 (w), 1331 (m), 1304 (m), 
1275 (w), 1223 (w), 1201 (w), 1174 (w), 1132 (m), 1092 (w), 1058 (w), 982 (w), 957 (w) cm-1; 
HRMS (ESI) calcd. for C18H19NNaO6+ [M+Na]+ 368.1105; found 368.1109. 
  
                                                          
9 The compound was isolated as a single diastereoisomer of which the relative configuration was not assigned. 
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5. Substrate synthesis 
 
(S)-Quinolin-4-yl((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methyl acetate (SI-34). 
 
Following a modified procedure,10 NEt3 (0.71 mL, 5.1 mmol, 1.5 equiv.) followed by acetyl chloride 
(0.32 mL, 4.4 mmol, 1.3 equiv.) were added to a suspension of cinchonine (SI-33) (1.00 g, 3.40 mmol, 
1 equiv.) in CH2Cl2 (17 mL, 0.2 M) at room temperature and the resulting mixture was stirred for 
16 hours. Thereafter water (20 mL) was added, the mixture was stirred for 30 minutes, then sat. aq. 
K2CO3 (20 mL) was added and the mixture was extracted with CH2Cl2 (3 x 20 mL). The comb. org. 
extracts were washed with brine (20 mL) and dried over MgSO4. The drying agent was filtered off and 
the solvent was evaporated. The residue was purified by column chromatography (silica, EtOAc:MeOH 
30:1) and 1.10 g (3.27 mmol, 96%) of the title compound SI-34 were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 8.88 (d, J = 4.5 Hz, 1H, ArH), 8.21 (d, J = 8.6 Hz, 1H, ArH), 8.16 – 8.09 (m, 
1H, ArH), 7.72 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H, ArH), 7.60 (ddd, J = 8.4, 6.8, 1.3 Hz, 1H, ArH), 7.38 (d, J = 
4.5 Hz, 1H, ArH), 6.58 (d, J = 6.9 Hz, 1H, CH), 6.02 (ddd, J = 17.4, 10.5, 7.3 Hz, 1H, CH=CH2), 5.18 – 5.02 
(m, 2H, CH=CH2), 3.30 (q, J = 8.5 Hz, 1H, CH), 2.92 (d, J = 9.2 Hz, 2H, CH2), 2.73 (ddd, J = 22.3, 14.6, 7.0 
Hz, 2H, CH2), 2.27 (q, J = 8.4 Hz, 1H, CH), 2.13 (s, 3H, C(O)CH3), 1.85 (dd, J = 18.2, 7.6 Hz, 2H, CH and 
CH2), 1.59 – 1.51 (m, 3H, CH2 and CH2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 169.8, 149.9, 148.6, 145.4, 140.2, 130.4, 129.2, 126.8, 126.0, 123.4, 
118.5, 114.9, 73.7, 59.5, 49.8, 49.0, 39.7, 27.8, 26.3, 23.6, 21.1; 
IR (film): ?̃? = 2940 (w), 2874 (w), 2364 (w), 2320 (w), 1747 (m), 1594 (w), 1510 (w), 1457 (w), 1374 (w), 
1276 (m), 1264 (s), 1231 (s), 1026 (m), 911 (m) cm-1; 
HRMS (ESI) calcd. for C21H25N2O2+ [M+H]+ 337.1911; found 337.1911. 
The analytical data match the literature report.10 
  
                                                          
10 J. Qi, A. B. Beeler, Q. Zhang, J. A. Porco J. Am. Chem. Soc. 2010, 132, 13642-13644. 
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5-(Quinolin-3-yl)pent-4-yn-1-ol (SI-37). 
 
Following a modified procedure,11 Pd(PPh3)2Cl2 (0.14 g, 0.20 mmol, 5 mol%) and pent-4-yn-1-ol (SI-36) 
(1.86 mL, 20.0 mmol, 5 equiv.) were added to a solution of 3-bromo-quinoline (SI-35) (0.54 mL, 
4.00 mmol, 1 equiv.) and CuI (76 mg, 0.40 mmol, 10 mol%) in triethylamine (8.00 mL, 0.5 M) at room 
temperature and the resulting mixture was then refluxed for 18 hours. Thereafter the reaction mixture 
was cooled to room temperature and filtered through a plug of Celite®. The filtrate was washed with 
brine (15 mL) and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. 
The residue was purified by column chromatography (silica, pentane:EtOAc 5:2) and 760 mg 
(3.60 mmol, 90%) of the title compound SI-37 were isolated as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 8.87 (s, 1H, ArH), 8.19 (d, J = 1.6 Hz, 1H, ArH), 8.12 (d, J = 8.3 Hz, 1H, 
ArH), 7.77 (d, J = 8.3 Hz, 1H, ArH), 7.71 (ddd, J = 8.3, 6.9, 1.6 Hz, 1H, ArH), 7.56 (t, J = 6.9 Hz, 1H, ArH), 
3.86 (t, J = 6.1 Hz, 2H, CH2-OH), 2.63 (t, J = 7.0 Hz, 2H, C≡C-CH2), 1.92 (p, J = 6.6 Hz, 2H, CH2-CH2-CH2); 
13C NMR (101 MHz, CDCl3): δ = 152.2, 146.3, 138.3, 129.9, 129.0, 127.4, 127.3, 127.2, 117.9, 93.2, 78.2, 
61.5, 31.3, 16.1 ppm; 
IR (film): ?̃? = 3333 (w), 2946 (w), 2361 (w), 2231 (w), 1570 (w), 1490 (m), 1433 (w), 1350 (w), 1266 (m), 
1126 (w), 1059 (s), 947 (w), 909 (s) cm-1; 
HRMS (ESI) calcd. for C14H14NO+ [M+H]+ 212.1070; found 212.1075. 
The analytical data match the literature report.11 
 
5-(Quinolin-3-yl)pent-4-yn-1-yl acetate (SI-38). 
 
Ac2O was added to a solution of alcohol SI-37 (200 mg, 0.947 mmol, 1 equiv.) and triethylamine 
(0.21 mL, 1.5 mmol, 1.6 equiv.) in CH2Cl2 (1.90 mL, 0.5 M) and the resulting mixture was stirred for 16 
hours at room temperature. The reaction was quenched by the addition of sat. aq. NaHCO3 (10 mL) 
and extracted with CH2Cl2 (3 x 20 mL). The comb. org. extracts were washed with brine (20 mL) and 
                                                          
11 A. Jean, J. Blanchet, J. Rouden, J. Maddalunob, M. de Paolis Chem. Commun. 2013, 49, 1651-1653. 
26 
 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. The residue was 
purified by column chromatography (silica, pentane:EtOAc 10:1 to 4:1) and 177 mg (0.70 mmol, 77%) 
of the title compound SI-38 were isolated as a colorless oil. 
Rf: 0.5 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 8.82 (d, J = 2.1 Hz, 1H, ArH), 8.10 (d, J = 2.1 Hz, 1H, ArH), 8.02 (dd, J = 
8.3, 1.3 Hz, 1H, ArH), 7.68 (dd, J = 8.3, 1.3 Hz, 1H, ArH), 7.62 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H, ArH), 7.47 
(ddd, J = 8.3, 6.9, 1.3 Hz, 1H, ArH), 4.20 (t, J = 6.3 Hz, 2H, CH2-OAc), 2.53 (t, J = 7.0 Hz, 2H, C≡C-CH2), 
2.02 (s, 3H, C(O)CH3), 1.97 – 1.88 (m, 2H, CH2-CH2-CH2); 
13C NMR (101 MHz, CDCl3): δ = 171.0, 152.2, 146.4, 138.2, 129.82, 129.1, 127.4, 127.3, 127.2, 117.8, 
92.3, 78.5, 63.1, 27.65, 20.9, 16.3 ppm; 
IR (film): ?̃? = 2964 (w), 2901 (w), 2364 (w), 2327 (w), 2233 (w), 1736 (s), 1568 (w), 1490 (w), 1366 (m), 
1238 (s), 1125 (w), 1043 (s) cm-1; 
HRMS (ESI) calcd. for C16H16NO2+ [M+H]+ 254.1176; found 254.1185. 
 
3-(5-((tert-Butyldimethylsilyl)oxy)pent-1-yn-1-yl)quinoline (SI-39). 
 
TBSCl (214 mg, 1.42 mmol, 1.5 equiv.) was added to a solution of alcohol SI-37 (200 mg, 0.947 mmol, 
1 equiv.) and triethylamine (0.21 mL, 1.5 mmol, 1.6 equiv.) in CH2Cl2 (1.60 mL, 0.5 M) and the resulting 
mixture was stirred for 16 hours at room temperature. The reaction was quenched by the addition of 
sat. aq. NH4Cl (10 mL) and extracted with CH2Cl2 (3 x 15 mL). The comb. org. extracts were washed with 
brine (20 mL) and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. 
The residue was purified by column chromatography (silica, pentane:EtOAc 10:1) and 275 mg 
(0.85 mmol, 89%) of the title compound SI-39 were isolated as a colorless oil. 
Rf: 0.5 (silica, pentane:EtOAc 10:1); 
1H NMR (400 MHz, CDCl3): δ = 8.87 (t, J = 1.6 Hz, 1H, ArH), 8.16 (t, J = 2.6 Hz, 1H, ArH), 8.11 – 8.04 (m, 
1H, ArH), 7.80 – 7.73 (m, 1H, ArH), 7.69 (m, 1H, ArH), 7.59 – 7.49 (m, 1H, ArH), 3.85 – 3.71 (m, 2H, CH2-
OTBS), 2.57 (td, J = 7.0, 1.7 Hz, 2H, C≡C-CH2), 1.92 – 1.78 (m, 2H, CH2-CH2-CH2), 0.92 (s, 9H, Si-tBu), 0.09 
(s, 6H, Si-(CH3)2); 
13C NMR (101 MHz, CDCl3): δ = 152.5, 146.5, 138.2, 129.9, 129.3, 127.6, 127.5, 127.3, 118.3, 93.8, 78.1, 
61.6, 31.7, 26.1, 18.5, 16.1, -5.2 ppm. 
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IR (film): ?̃? = 2953 (m), 2929 (m), 2856 (m), 2365 (w), 2233 (w), 1490 (w), 1472 (w), 1463 (w), 1276 (m), 
1258 (s), 1103 (s), 1071 (m) cm-1; 
HRMS (ESI) calcd. for C20H28NOSi+ [M+H]+ 326.1935; found 326.1945. 
 
6-Phenylquinoline (SI-41). 
 
Following a modified procedure,12 a mixture of 6-bromo-quinoline (SI-40) (0.70 mL, 5.00 mmol, 
1 equiv.), sodium carbonate (2.12 g, 20.0 mmol, 4 equiv.), phenylboronic acid (732 mg, 6.00 mmol, 
1.2 equiv.), water (4 mL), toluene (4 mL) and ethanol (2 mL) was degassed by nitrogen bubbling, then 
Pd(PPh3)4 (0.29 g, 0.25 mmol, 5 mol%) was added and the mixture was heated to 75 °C for 12 hours. 
Thereafter the mixture was filtered through a plug of celite®, the filtrate was diluted with water (20 mL) 
and extracted with CH2Cl2 (3 x 20 mL). The combined org. extracts were washed with brine (20 mL) and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. The residue was 
purified by column chromatography (silica, pentane:EtOAc 10:1 to 4:1 to 1:1) and 740 mg (3.61 mmol, 
72%) of the title compound SI-41 were isolated as a red-brown oil. 
1H NMR (400 MHz, CDCl3): δ = 8.93 (dd, J = 4.3, 1.7 Hz, 1H, ArH), 8.23 (dt, J = 7.4, 2.6 Hz, 2H, ArH), 8.04 
– 7.95 (m, 2H, ArH), 7.77 – 7.67 (m, 2H, ArH), 7.51 (dd, J = 8.4, 6.9 Hz, 2H, ArH), 7.47 – 7.38 (m, 2H, 
ArH) ppm. 
13C NMR (101 MHz, CDCl3): δ = 150.0, 147.2, 140.2, 139.5, 136.6, 129.6, 129.4, 129.0, 128.5, 127.8, 
127.4, 125.4, 121.4 ppm. 
IR (film): ?̃? = 3015 (w), 2326 (w), 1903 (w), 1775 (w), 1685 (w), 1591 (m), 1489 (s), 1444 (m), 1328 (m), 
1276 (s), 1261 (s), 1188 (w), 1123 (m), 1040 (w), 891 (m), 845 (s) cm-1. 
HRMS (ESI) calcd. for C15H12N+ [M+H]+ 206.0964; found 206.0967. 
The analytical data match the literature report.12 
  
                                                          
12 L. Mengozzi, A. Gualandi, P.-G. Cozzi Eur. J. Org. Chem. 2016, 19, 3200-3207. 
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Quinoline-6-carbonitrile (SI-42). 
 
Following a modified procedure,13 6-bromoquinoline (SI-40) (0.70 mL, 5.00 mmol, 1 equiv.), Zn(CN)2 
(881 mg, 7.50 mmol, 1.5 equiv.) and dppf (0.28 mg, 0.50 mmol, 10 mol%) were dissolved in DMF 
(10 mL, 0.5 M), the mixture was degassed by N2 bubbling for 10 minutes, then Pd2dba3 (0.23 g, 
0.25 mmol, 5 mol%) was added and the mixture was heated to 130 °C for 14 hours. After cooling to 
room temperature the reaction was quenched with water (20 mL) and the mixture was extracted with 
EtOAc (3 x 20 mL). The comb. org. extracts were washed with brine (20 mL) and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. The crude product was purified by 
column chromatography (silica, pentane:EtOAc 5:1) and 581 mg (3.77 mmol, 75%) of the title 
compound SI-42 were isolated as an orange oil. 
1H NMR (400 MHz, CDCl3): δ = 9.07 (dd, J = 4.3, 1.7 Hz, 1H, ArH), 8.30 – 8.16 (m, 3H, ArH), 7.88 (dd, J = 
8.7, 1.7 Hz, 1H, ArH), 7.56 (dd, J = 8.4, 4.3 Hz, 1H, ArH); 
13C NMR (101 MHz, CDCl3): δ = 153.1, 149.0, 136.5, 134.1, 131.0, 130.2, 127.6, 122.7, 118.5, 110.5 ppm. 
IR (film): ?̃? = 2987 (s), 2901 (m), 2328 (w), 1764 (w), 1699 (w), 1543 (w), 1509 (w), 1413 (m), 1339 (m), 
1233 (s), 1059 (s) cm-1; 
HRMS (ESI) calcd. for C10H7N2+ [M+H]+ 155.0604; found 155.0603. 
The analytical data match the literature report.13  
 
6-Methoxy-5-nitroquinoline (SI-44). 
 
Following a modified procedure,14 6-methoxy-quinoline (SI-43) (1.00 mL, 7.22 mmol) was added 
dropwise to a mixture of H2SO4 (4.00 mL) and HNO3 (4.00 mL) at 0 °C and the resulting mixture was 
stirred for 1 hour. The reaction was basified with sat. aq. Na2CO3 and extracted with CH2Cl2 (3 x 50 mL). 
The comb. org. extracts were washed with brine (50 mL) and dried over MgSO4. The drying agent was 
                                                          
13 F. Zhao, J. Zhang, L. Zhang, Y. Hao, C. Shi, G. Xia, J. Yu, , Y. Liu Bioorg.Med. Chem. 2016, 24, 4281-4290. 
14 H.-Y. Lee, J.-Y. Chang, C.-Y. Nien, C.-C. Kuo, K.-H. Shih, C.-H. Wu, C.-Y. Chang, W.-Y. Lai, J.-P. Liou J. Med. Chem. 2011, 54, 8517-8525. 
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filtered off and the solvent was evaporated. The crude product was purified by column 
chromatography (SiO2, pentane:EtOAc 1:1) and 1.14 g (5.58 mmol, 77%) of the title compound SI-44 
were isolated as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 8.88 (dd, J = 4.1, 1.5 Hz, 1H, ArH), 8.28 (d, J = 9.5 Hz, 1H, ArH), 8.08 (d, J 
= 8.7 Hz, 1H, ArH), 7.59 (d, J = 9.5Hz, 1H, ArH), 7.53 (dd, J = 8.7, 4.1 Hz, 1H, ArH), 4.08 (s, 3H, OCH3). 
13C NMR (101 MHz, CDCl3): δ = 149.5, 149.2, 142.3, 134.6, 134.1, 129.2, 123.6, 121.4, 116.3, 57.2 ppm; 
IR (film): ?̃? = 2978 (s), 2909 (m), 2350 (w), 1648 (w), 1516 (w), 1389 (w), 1245 (w), 1068 (s), 878 (w)  
cm-1; 
HRMS (ESI) calcd. for C10H9N2O3+ [M+H]+ 205.0608; found 205.0612. 
The analytical data match the literature report.14 
 
Isoquinoline-4-carbonitrile (SI-46). 
 
Following a modified procedure,15 Pd(PPh3)4 (0.29 g, 0.25 mmol, 8 mol%) was added in one portion to 
a solution of 4-bromoisoquinoline (SI-45) (624 mg, 3.00 mmol, 1 equiv.) and Zn(CN)2 (352 mmol, 
3.00 mmol, 1 equiv.) in DMF (5 mL, 0.6 M) and the resulting mixture was heated to 80 °C for 16 hours. 
The reaction was quenched with sat. aq. Na2CO3 (10 mL) and the mixture was extracted 3 times with 
CH2Cl2 (10 mL). The combined org. extracts were washed with brine (15 mL) and the solvent was 
evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 4:1) and 
412 mg (2.67 mmol, 89%) of the title compound SI-46 were isolated as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 9.30 (s, 1H, ArH), 8.76 (s, 1H, ArH), 8.07 – 7.92 (m, 2H, ArH), 7.81 (ddd, 
J = 8.2, 6.9, 1.1 Hz, 1H, ArH), 7.68 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H, ArH); 
13C NMR (101 MHz, CDCl3): δ = 155.9, 147.9, 134.0, 132.7, 128.9, 128.2, 127.1, 123.6, 115.6, 105.5; 
IR (film): ?̃? = 3058 (w), 2230 (m), 1623 (m), 1578 (w), 1502 (m), 1390 (m), 1380 (m), 1268 (s), 1221 (w), 
1149 (w), 909 (m) cm-1; 
HRMS (ESI) calcd. for C10H7N2+ [M+H]+ 155.0604; found 155.0602. 
The analytical data match the literature report.15  
 
                                                          
15 J. C. Barrow, B. D. Dorsey, H. G. Selnick, P. L. Ngo WO2001070229 A1. 
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Methyl isoquinoline-4-carboxylate (SI-48). 
 
TMS diazomethane (1.08 mL, 2.17 mmol, 2 M in Et2O) was added dropwise to a suspension of 
isoquinoline-4-carboxylic acid SI-47 (250 mg, 1.44 mmol) in CH2Cl2 (10 mL) and CH3OH (4 mL) at 0 °C. 
The resulting mixture was stirred for 16 hours while warming to room temperature, then the solvent 
was evaporated. The residue was purified by column chromatography (silica, pentane:EtOAc 3:1) 
affording 232 mg (1.24 mmol, 86%) of the title compound SI-48 as a white solid. 
1H NMR (400 MHz, CDCl3): δ = 9.38 (s, 1H), 9.19 (s, 1H), 8.96 (dq, J = 8.8, 0.9 Hz, 1H), 8.05 (dd, J = 8.2, 
1.1 Hz, 1H), 7.91 – 7.81 (m, 1H), 7.69 (m, 1H), 4.04 (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 166.8, 156.9, 146.7, 133.9, 132.3, 128.4, 128.3, 127.7, 125.0, 120.5, 
52.3; 
IR (film): ?̃? = 3014 (w), 2958 (w), 1722 (s), 1624 (w), 1572 (w), 1505 (m), 1436 (m), 1378 (w), 1294 (s), 
1238 (w), 1208 (s), 1143 (m), 1045 (m), 1023 (w), 918 (w), 866 (m) cm-1; 
HRMS (ESI) calcd. for C11H10NO2+ [M+H]+ 188.0706; found 188.0713. 
The analytical data match the literature report.16  
 
4-(5-Hydroxypent-1-yn-1-yl)nicotinonitrile (SI-50). 
 
4-Pentynol (712 µL, 7.65 mmol, 4 equiv.) was added to a degassed (pump and freeze, 3 cycles) solution 
of 4-bromonicotinonitrile (SI-49) (350 mg, 1.91 mmol, 1 equiv.) Pd(PPh3)2Cl2 (67 mg, 10 µmol, 5 mol%) 
and CuI (36 mg, 0.19 mmol, 10 mol%) in NEt3 (3.8 mL, 0.5 M) and the resulting mixture was heated to 
40 °C for 1.5 hours. After cooling to room temperature, sat. aq. NH4Cl (15 mL) was added and the 
mixture was extracted with CH2Cl2 (3 x 10 mL). The combined org. extracts were washed with brine 
and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. The residue 
was purified by column chromatography (silica, pentane:EtOAc 1:1 to 1:2) and 332 mg (1.78 mmol, 
93%) of the title compound SI-50 were isolated as an orange oil. 
                                                          
16 J. R. Martinelli, D. A. Watson, D. M. Freckmann, T. E. Barder, S. L. Buchwald J. Org. Chem. 2008, 73, 7102-7107. 
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Rf: 0.2 (silica, pentane:EtOAc 1:1); 
1H NMR (400 MHz, CDCl3): δ = 8.81 (s, 1H, ArH), 8.69 (d, J = 5.2 Hz, 1H, ArH), 7.36 (d, J = 5.2 Hz, 1H, 
ArH), 3.85 (t, J = 6.1 Hz, 2H, CH2OH), 2.67 (t, J = 6.9 Hz, 2H, C≡C-CH2), 1.91 (p, J = 6.5 Hz, 3H, CH2 and 
OH underneath); 
13C NMR (101 MHz, CDCl3): δ = 152.5, 152.3, 135.6, 125.5, 115.8, 112.2, 103.4, 75.9, 61.0, 30.6, 16.2 
ppm. 
IR (film): ?̃? = 3396 (w), 2932 (w), 2877 (w), 2235 (m), 1584 (s), 1537 (w), 1486 (w), 1409 (w), 1186 (w), 
1058 (m) cm-1; 
HRMS (ESI) calcd. for C11H11N2O+ [M+H]+ 187.0866; found 187.0865. 
 
4-(5-((tert-Butyldimethylsilyl)oxy)pent-1-yn-1-yl)nicotinonitrile (SI-51). 
 
TBSCl (389 mg, 2.58 mmol, 1.5 equiv.) was added to a solution of SI-50 (320 mg, 1.78 mmol, 1 equiv.) 
and NEt3 (480 µL, 3.44 mmol, 2 equiv.) in CH2Cl2 (3.4 mL) at room temperature and the mixture was 
stirred for 16 hours. The reaction was quenched with sat. aq. NH4Cl (15 mL) and extracted with CH2Cl2 
(3 x 10 mL). The combined org. extracts were washed with brine and dried over MgSO4. The drying 
agent was filtered off and the solvent was evaporated. The residue was purified by column 
chromatography (silica, pentane:EtOAc 10:1 to 5:1) and 404 mg (1.35 mmol, 78%) of the title 
compound SI-51 were isolated as an orange oil. 
Rf: 0.7 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 8.81 (d, J = 0.9 Hz, 1H, ArH), 8.68 (d, J = 5.3 Hz, 1H, ArH), 7.35 (dd, J = 
5.3, 0.9 Hz, 1H, ArH), 3.77 (t, J = 5.9 Hz, 2H, CH2OTBS), 2.63 (t, J = 7.1 Hz, 2H, C≡C-CH2), 1.86 (tt, J = 7.1, 
5.9 Hz, 2H, CH2), 0.90 (s, 9H, C(CH3)3), 0.07 (s, 6H, Si(CH3)2); 
13C NMR (101 MHz, CDCl3): δ = 152.6, 152.2, 135.7, 125.6, 115.7, 112.1, 104.0, 75.6, 61.2, 31.1, 25.9, 
18.3, 16.2, -5.4 ppm; 
IR (film): ?̃? = 2956 (m), 2931 (w), 2855 (w), 2236 (w), 1583 (m), 1537 (w), 1485 (w), 1408 (w), 1107 (s), 
838 (s) cm-1; 
HRMS (ESI) calcd. for C17H25N2OSi+ [M+H]+ 301.1731; found 301.1730. 
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4-(5-((tert-Butyldimethylsilyl)oxy)pentyl)nicotinonitrile (SI-52). 
 
Pd(OH)2/C (34 mg, 20% Pd, 10%w/w) was added to a solution of SI-51 (340 mg, 1.13 mmol) in CH3OH 
(2.3 mL, 0.5 M) and the resulting mixture was purged with hydrogen and thereafter stirred for 18 hours 
under H2-atmosphere (1 atm). Then the mixture was filtered through a plug of Celite® and 
concentrated. The residue was purified by column chromatography (silica, pentane:EtOAc 10:1 to 5:1) 
affording 243 mg (0.80 mmol, 71%) of the title compound SI-52 as a colorless oil. 
Rf: 0.7 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 0.8 Hz, 1H, ArH), 8.65 (d, J = 5.2 Hz, 1H, ArH), 7.26 (dd, J = 
5.2, 0.8 Hz, 1H, ArH), 3.60 (t, J = 6.3 Hz, 2H, CH2OTBS), 2.90 – 2.77 (m, 2H, Ar-CH2), 1.76 – 1.65 (m, 2H 
CH2), 1.60 – 1.50 (m, 2H CH2), 1.47 – 1.36 (m, 2H CH2), 0.86 (s, 9H, C(CH3)3), 0.02 (s, 6H Si(CH3)2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 155.3, 152.9, 152.5, 123.9, 115.9, 110.4, 62.7, 34.0, 32.3, 29.6, 25.9, 
25.4, 18.3, -5.3 ppm. 
IR (film): ?̃? = 2931 (w), 2857 (w), 2229 (w), 1590 (w), 1556 (w), 1472 (w), 1463 (w), 1407 (w), 1255 (m), 
834 (s) cm-1; 
HRMS (ESI) calcd. for C17H25N2OSi+ [M+H]+ 301.1731; found 301.1730. 
 
1,1,1,3,3,3-Hexafluoropropan-2-yl nicotinate (SI-54). 
 
Following a modified procedure,17 TEMPO (161 mg, 1.03 mmol, 5 mol%) followed by 
trichloroisocyanuric acid (5.75 g, 24.7 mmol, 1.2 equiv.) were added to a solution of pyridine-3-
ylmethanol (SI-53) (2.00 mL, 20.6 mmol, 1 equiv.) in CH2Cl2 (41.2 mL, 0.5 M) at 0 °C and the resulting 
mixture was stirred for 2 hours. Thereafter pyridine (6.70 mL, 82.0 mmol, 4 equiv.) followed by 
1,1,1,3,3,3-hexafluoropropan-2-ol (4.40 mL, 41.2 mmol, 2 equiv.) were added and stirring was 
continued for 16 hours at room temperature. The reaction mixture was filtered through a plug of 
                                                          
17 J.-M. Vatéle Synlett 2015, 26, 2280-2284. 
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Celite® and concentrated. The residue was purified by column chromatography (silica, pentane:EtOAc 
5:1) affording 4.53 g (16.6 mmol, 81%) of the title compound SI-54 as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 9.28 (dd, J = 2.2, 0.8 Hz, 1H, ArH), 8.86 (dd, J = 4.9, 1.7 Hz, 1H, ArH), 8.42 
(ddd, J = 8.0, 2.2, 1.7 Hz, 1H, ArH), 7.54 (ddd, J = 8.0, 4.9, 0.8 Hz, 1H, ArH), 6.02 (p, J = 6.0 Hz, 1H, 
CH(CF3)2); 
13C NMR (101 MHz, CDCl3): δ = 161.9, 154.5, 151.0, 138.3, 124.0, 123.4, 120.7 (q, J = 282.6 Hz), 67.1 (p, 
J = 67.2 Hz); 
19F NMR (376 MHz, CDCl3): δ = -75.60 (d, J = 5.8 Hz); 
IR (film): ?̃? = 1764 (m), 1595 (w), 1426 (w), 1386 (w), 1361 (w), 1297 (m), 1266 (m), 1197 (s), 1101 (s), 
1017 (w), 912 (m) cm-1; 
HRMS (ESI) calcd for C9H6F6NO2+ [M+H]+ 274.0297; found 274.0300. 
The analytical data match the literature report.18 
 
Methyl 4-chloronicotinate (SI-56). 
 
Following a modified procedure,19 trimethylsilyldiazomethane (4.76 mL, 9.52 mmol, 1.5 equiv.) was 
added dropwise to a suspension of chloronicotinic acid (SI-55) (1.00 g, 6.35 mmol, 1 equiv.) in a 
mixture of CH2Cl2 (5.5 mL) and methanol (2.2 mL) at 0 °C. The resulting mixture was warmed to room 
temperature and stirred for 1 hour, then concentrated and the residue was purified by column 
chromatography (silica, pentane:EtOAc 10:1 to 5:1) affording 1.02 g (5.92 mmol, 93%) of the title 
compound SI-56 as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 9.03 (t, J = 0.6 Hz, 1H), 8.58 (dd, J = 5.4, 0.6 Hz, 1H), 7.49 – 7.28 (m, 1H), 
3.97 (s, 3H) ppm; 
13C NMR (101 MHz, CDCl3): δ = 164.2, 152.6, 152.2, 144.2, 125.9, 125.8, 52.7 ppm; 
IR (film): ?̃? = 3003 (w), 2953 (w), 1725 (s), 1627 (w), 1573 (m), 1436 (m), 1292 (s), 1275 (s), 1130 (m), 
1082 (s), 1046 (w), 955 (w), 832 (m) cm-1; 
HRMS (ESI) calcd. for C7H7ClNO2+ [M+H]+ 172.0160; found 172.0161. 
The analytical data match the literature report.19  
                                                          
18 C. B. Kelly, M. A. Mercadante, R. J. Wiles, N. E. Leadbeater Org. Lett. 2013, 15, 2222-2225. 
19 D. Norton, D. Andreotti, S. E. Ward, R. Profeta, S. Spada, H. S. Price WO 2012098400 A1. 
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6. Optimization of the reaction 
Table S7 Optimization of the annulation of quinoline (8) and cyclopropane 14. 
 
Entry 14 Lewis Acid (mol%) Conc. Result[a] Comment[b] 
1 1.0 equiv. Sc(OTf)3 (20 mol%) 0.1 M 30% of 17 full conversion of cyclopropane 
2 1.0 equiv. Sc(OTf)3 (20 mol%) 0.05 M 62% of 17 full conversion of cyclopropane 
3 1.5 equiv. Sc(OTf)3 (20 mol%) 0.1 M 69% of 17 full conversion of cyclopropane 
4 1.5 equiv. Sc(OTf)3 (20 mol%) 0.05 M 80% of 17 full conversion of cyclopropane 
5 1.5 equiv. Sn(OTf)2 (20 mol%) 0.05 M no conversion  
6 1.5 equiv. In(OTf)3 (20 mol%) 0.05 M no conversion  
7 1.5 equiv. Cu(OTf)2 (20 mol%) 0.05 M no conversion  
8 1.5 equiv. Hf(OTf)4 (20 mol%) 0.05 M decomposition  
9 1.5 equiv. FeCl3 (20 mol%) 0.05 M no conversion  
10 1.5 equiv. FeCl2 (20 mol%) 0.05 M no conversion  
11 1.5 equiv. InCl3 (20 mol%) 0.05 M no conversion  
12 1.5 equiv. MgCl2 (20 mol%) 0.05 M no conversion  
13 1.5 equiv. Yb(OTf)3 (20 mol%) 0.05 M 90% of 17 remaining cyclopropane 
14 1.1 equiv. Yb(OTf)3 (20 mol%) 0.05 M 88% of 17  
15 1.05 equiv. Yb(OTf)3 (10 mol%) 0.05 M 89% of 17 reaction time: 2 days  
16 1.05 equiv. Yb(OTf)3 (5 mol%) 0.05 M 96% of 17 reaction time: 4 days 
17 1.05 equiv. Yb(OTf)3 (5 mol%) 0.5 M 96% of 17 reaction time: 16 hours 
18 1.05 equiv. HOTf (20 mol%) 0.2 M no conversion  
1 [a] Yields determined by isolation; [b] remaining cyclopropane was detected by TLC.  
 
Experimental procedure for optimization 
A vial was charged with cyclopropane 14, the Lewis acid and quinoline 8 (0.10 mmol, 1.00 equiv.) in 
the glovebox, then capped, removed from the glovebox and CH2Cl2 was added. The mixture was 
stirred, if not stated otherwise in the table, for 16 hours, then concentrated and the residue was 
purified by column chromatography. 
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7. General procedure 
 
 
A vial was charged with cyclopropane (0.21 mmol, 1.05 equiv.), Yb(OTf)3 (0.01 mmol, 5 mol% or 
0.02 mmol, 10 mol%) and the N-heterocyclic compound (0.20 mmol, 1.00 equiv.) in the glovebox, then 
capped, removed from the glovebox and CH2Cl2 was added. The mixture was stirred for the indicated 
time, then concentrated and the residue was purified by column chromatography to afford the title 
compound. 
 
8. Scope of the reaction with quinolines 
 
anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (17). 
 
Following the general procedure quinoline (8) (260 mg, 2.00 mmol, 1.00 equiv.), cyclopropane 14 
(640 mg, 2.10 mmol, 1.05 equiv.) and Yb(OTf)3 (62 mg, 0.10 mmol, 5 mol%) were stirred in CH2Cl2 
(4.0 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 10:1 to 4:1) and 820 mg (1.90 mmol, 95%) of the title compound 17 were isolated as a 
yellow oil which was crystallized from EtOAc by overlaying it with pentane. 
Performing the reaction with quinoline 8 (26 mg, 0.20 mmol), 14 (64 mg, 0.21 mmol) and Yb(OTf)3 
(6 mg, 0.01 mmol) afforded 83 mg (0.19 mmol, 96%) of the title compound 17. 
mp: 127-129 °C; 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
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1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.95 (td, J = 7.9, 1.6 Hz, 1H, ArH), 6.78 (dd, J = 7.4, 1.6 Hz, 1H, ArH), 6.55 (td, J = 7.4, 1.0 Hz, 1H, ArH), 
6.42 (d, J = 7.9 Hz, 1H, ArH), 6.30 (dd, J = 10.2, 2.0 Hz, 1H, C=CH), 6.21 (dd, J = 8.6, 5.9 Hz, 1H, N-CH-
Phth), 5.94 (t, J = 2.5 Hz, 1H, CH-N), 5.85 (dd, J = 10.2, 2.9 Hz, 1H, CH=CH), 3.82 (s, 3H, OCH3), 3.63 (s, 
3H, OCH3), 2.98 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.53 (dd, J = 13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.1, 167.7, 141.6, 134.3, 131.7, 129.5, 127.2, 126.2, 123.4, 
120.4, 119.4, 118.0, 109.7, 67.3, 65.3, 64.4, 52.7, 52.6, 35.3 ppm; 
IR (film): ?̃? = 3050 (w), 2996 (w), 2953 (w), 1721 (s), 1604 (w), 1497 (w), 1458 (w), 1442 (w), 1390 (w), 
1357 (m), 1321 (m), 1273 (s), 1222 (w), 1141 (w), 1078 (w), 969 (w) cm-1; 
HRMS (ESI) calcd. for C24H20N2NaO6+ [M+Na]+ 455.1214; found 455.1223. 
 
anti-Dimethyl 5-chloro-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (20). 
 
Following the general procedure 4-chloroquinoline (SI-57) (33 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 84 mg (0.18 mmol, 90%) of the title compound 20 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.73 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.32 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 7.03 (td, J = 7.8, 1.6 Hz, 1H, ArH), 6.63 (td, J = 7.5, 1.0 Hz, 1H, ArH), 
6.44 (d, J = 8.2 Hz, 1H, ArH), 6.20 (dd, J = 8.6, 5.9 Hz, 1H, CH-Phth), 6.06 (d, J = 3.3 Hz, 1H, CH=CCl), 5.97 
(d, J = 3.3 Hz, 1H, CH-N), 3.83 (s, 3H, OCH3), 3.66 (s, 3H, OCH3), 3.00 (dd, J = 13.8, 8.6 Hz, 1H, CH2), 2.51 
(dd, J = 13.8, 5.9 Hz, 1H, CH2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 169.6, 168.7, 167.6, 142.1, 134.4, 131.5, 130.8, 129.6, 125.2, 123.5, 
118.2, 118.1, 117.1, 109.9, 67.1, 65.1, 65.0, 52.9, 52.8, 35.0 ppm; 
IR (film): ?̃? = 2955 (w), 2925 (w), 2852 (w), 1772 (w), 1732 (s), 1710 (s), 1647 (w), 1598 (w), 1491 (m), 
1458 (w), 1436 (w), 1396 (w), 1354 (w), 1276 (m), 1266 (s) cm-1; 
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HRMS (ESI) calcd. for C24H20ClN2O6+ [M+H]+ 467.1004; found 467.0997. 
 
anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-5-methyl-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (21). 
 
Following the general procedure lepidine (SI-58) (29 mg, 0.20 mmol, 1.00 equiv.), cyclopropane 14 
(64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 
0.5 M) for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 
10:1 to 4:1) and 83 mg (0.19 mmol, 93%) of the title compound 21 were isolated as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.98 (td, J = 7.3, 1.3 Hz, 2H, ArH), 6.60 (td, J = 7.3, 1.3 Hz, 1H, ArH), 6.44 (d, J = 8.2 Hz, 1H, ArH), 6.22 
(dd, J = 8.6, 5.9 Hz, 1H, CH-Phth), 5.87 (dd, J = 3.1, 1.6 Hz, 1H, CH-N), 5.73 (dd, J = 3.1, 1.6 Hz, 1H, 
CH=CCH3), 3.82 (s, 3H, OCH3), 3.59 (s, 3H, OCH3), 2.98 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.51 (dd, J = 13.7, 
5.9 Hz, 1H, CH2), 1.98 (t, J = 1.6 Hz, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.3, 167.7, 141.8, 134.3, 131.7, 130.7, 129.3, 123.8, 123.4, 
120.6, 117.8, 117.8, 109.7, 67.6, 65.2, 64.1, 52.7, 52.5, 35.3, 19.0; 
IR (film): ?̃?  2987 (s), 2972 (s), 2902 (m), 2362 (w), 1717 (w), 1406 (w), 1395 (w), 1384 (w), 1276 (w), 
1258 (w), 1231 (w), 1076 (s), 1066 (s), 1057 (s) cm-1; 
HRMS (ESI) calcd for C25H23N2O6+ [M+H]+ 447.1551; found 447.1548. 
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(1R,3aR)-Dimethyl 5-((S)-acetoxy((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methyl)-1-(1,3-
dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (22a) and (1S,3aS)-
dimethyl 5-((S)-acetoxy((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methyl)-1-(1,3-dioxoisoindolin-2-yl)-
1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (22b) 
 
Following the general procedure SI-34 (67 mg, 0.20 mmol, 1.00 equiv.), cyclopropane 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, EtOAc:CH3OH 30:1 to 
20:1) and 97 mg (0.15 mmol, 76%) of the title compounds 22a and 22b were isolated as a yellow oil 
and 1:1 mixture of diastereoisomers.20 
Rf: 0.1 (silica, EtOAc: CH3OH 30:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (d, J = 5.7 Hz, 4H), 7.78 – 7.69 (m, 4H), 7.18 (m, 2H, ArH), 7.00 (m, 
2H, ArH), 6.63 (m, 2H, ArH), 6.44 (m, 2H, ArH), 6.17 (m, 2H, CH-Phth), 6.06 – 5.87 (m, 6H, =CH-N, CH-O 
and CH=CH2), 5.84 (d, J = 8.1 Hz, 2H, C=CH), 5.29 – 4.96 (m, 4H, =CH2), 3.82 (m, 6H, OCH3), 3.62 (s, 3H, 
OCH3), 3.55 (s, 3H, OCH3), 3.23 – 2.86 (m, 12H, 3 x CH2), 2.63 – 2.27 (m, 4H, CH2), 2.14 (s, 6H, C(O)CH3), 
1.97 – 1.43 (m, 10H, CH2, 3 x CH); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.6, 169.2, 169.1, 168.7, 167.8, 167.7, 142.0, 141.6, 139.1, 
138.7, 134.4, 132.7, 132.2, 131.6, 130.0, 129.7, 123.5, 123.1, 118.5, 118.1, 117.4, 116.8, 115.9, 115.6, 
110.4, 67.9, 66.5, 65.3, 64.7, 64.0, 63.7, 57.4, 57.3, 53.1, 52.9, 52.8, 52.7, 50.0, 49.8, 49.2, 49.0, 38.8, 
38.5, 35.7, 34.9, 27.8, 27.7, 25.4, 25.1, 21.2, 21.2;21 
IR (film): ?̃?  2987 (w), 2958 (w), 2902 (w), 1732 (s), 1714 (s), 1599 (w), 1498 (w), 1458 (w), 1437 (w), 
1396 (w), 1363 (w), 1328 (w), 1268 (m), 1231 (s), 1211 (m), 1126 (w), 1105 (w), 1078 (m), 1031 (m), 
967 (w), 919 (w), 879 (w) cm-1; 
HRMS (ESI) calcd. for C36H38N3O8+ [M+H]+ 640.2653; found 640.2647. 
  
                                                          
20 The diastereomeric ratio was determined by integration of the methyl esters in the 1H-NMR. Both the diastereoisomers were not 
individually assigned due to overlapping signals in 1H-NMR. 
21 Some olefinic carbons are overlapping. 
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anti-Dimethyl 4-bromo-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (23). 
 
Following the general procedure 6-bromoquinoline (SI-35) (41 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 94 mg (0.18 mmol, 92%) of the title compound 23 were isolated 
as an orange oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.74 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.05 – 6.90 (m, 1H, ArH), 6.76 (dd, J = 7.5, 1.5 Hz, 1H, ArH), 6.74 – 6.65 (m, 1H, CH=CBr), 6.58 (td, J = 
7.5, 1.5 Hz, 1H, ArH), 6.42 (d, J = 8.2 Hz, 1H, ArH), 6.28 (d, J = 1.4 Hz, 1H, CH-N), 6.15 (dd, J = 8.4, 7.0 
Hz, 1H, CH-Phth), 3.84 (s, 3H, OCH3), 3.67 (s, 3H, OCH3), 3.11 (dd, J = 13.0, 8.4 Hz, 1H, CH2), 2.72 (dd, J 
= 13.0, 7.0 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 168.6, 168.4, 167.5, 140.2, 134.4, 131.6, 130.0, 129.5, 126.8, 123.6, 
118.9, 118.6, 115.4, 109.7, 70.5, 66.8, 65.5, 52.9, 52.7, 37.1 ppm; 
IR (film): ?̃? = 2955 (w), 2901 (w), 1772 (w), 1731 (m), 1714 (s), 1598 (w), 1495 (m), 1398 (w), 1365 (w), 
1352 (w), 1264 (s), 1229 (w), 1134 (m), 1079 (m) cm-1; 
HRMS (ESI) calcd. for C24H18BrN2O6 [M+] 509.0343; found 509.0359. 
 
anti-Dimethyl 4-(5-acetoxypent-1-yn-1-yl)-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-
a]quinoline-3,3(3aH)-dicarboxylate (24). 
 
Following the general procedure SI-38 (51 mg, 0.20 mmol, 1.00 equiv.), cyclopropane 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
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for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 88 mg (0.16 mmol, 79%) of the title compound 24 were isolated as a yellow oil. 
Rf: 0.2 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.93 (td, J = 8.0, 1.5 Hz, 1H, ArH), 6.75 (dd, J = 7.4, 1.5 Hz, 1H, ArH), 6.54 (t, J = 7.4 Hz, 1H, ArH), 6.50 
(d, J = 1.5 Hz, 1H, CH=C), 6.38 (d, J = 8.0 Hz, 1H, ArH), 6.17 – 6.08 (m, 2H, CH-N and CH-Phth), 4.19 (t, J 
= 6.3 Hz, 2H, CH2-O), 3.80 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 3.04 (dd, J = 13.1, 8.4 Hz, 1H, CH2), 2.63 (dd, 
J = 13.1, 6.5 Hz, 1H, CH2), 2.45 (t, J = 7.0 Hz, 2H, C≡C-CH2), 2.06 (s, 3H, COCH3), 1.88 (p, J = 6.7 Hz, 2H, 
CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.9, 169.3, 168.7, 167.5, 140.9, 134.3, 131.6, 131.4, 130.0, 127.2, 
123.5, 123.4, 119.2, 118.3, 114.5, 109.5, 91.9, 79.1, 67.0, 66.6, 65.1, 63.1, 52.6, 52.5, 37.3, 27.6, 20.9, 
16.4 ppm; 
IR (film): ?̃?  2954 (w), 2851 (w), 1773 (w), 1731 (s), 1711 (s), 1597 (w), 1495 (w), 1459 (w), 1436 (w), 
1397 (w), 1365 (w), 1353 (w), 1259 (s), 1242 (s), 1134 (w), 1075 (w), 1044 (w) cm-1; 
HRMS (ESI) calcd. for C23H24NO6 [M+] 410.1598; found 410.1605. 
 
anti-Dimethyl 4-(5-((tert-butyldimethylsilyl)oxy)pent-1-yn-1-yl)-1-(1,3-dioxoisoindolin-2-yl)-1,2-
dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (25). 
 
Following the general procedure SI-39 (65 mg, 0.20 mmol, 1.00 equiv.), cyclopropane 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 6:1) and 88 mg (0.16 mmol, 81%) of the title compound 25 were isolated as a yellow oil. 
Rf: 0.5 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.93 (td, J = 7.6, 1.5 Hz, 1H, ArH), 6.76 (dd, J = 7.6, 1.5 Hz, 1H, ArH), 6.60 – 6.51 (m, 1H, ArH), 6.49 (d, J 
= 1.5 Hz, 1H, CH=C), 6.38 (d, J = 8.1 Hz, 1H, ArH), 6.17 – 6.08 (m, 2H, CH-N and CH-Phth), 3.81 (s, 3H, 
OCH3), 3.72 (t, J = 6.0 Hz, 2H, CH2O), 3.65 (s, 3H, OCH3), 3.05 (dd, J = 13.1, 8.4 Hz, 1H, CH2), 2.67 (dd, J 
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= 13.1, 6.6 Hz, 1H, CH2), 2.43 (t, J = 7.2 Hz, 2H, C≡CCH2), 1.81 – 1.72 (m, 2H, CH2), 0.90 (s, 9H, SiC(CH3)3), 
0.07 (s, 6H, Si(CH3)2); 
13C NMR (101 MHz, CDCl3): δ = 169.3, 168.7, 167.5, 140.9, 134.3, 131.7, 130.9, 129.9, 127.2, 123.5, 
119.4, 118.3, 114.9, 109.5, 93.3, 78.5, 67.2, 66.6, 65.2, 61.7, 52.6, 52.5, 37.4, 31.8, 25.9, 18.3, 16.1, -
5.4; 
IR (film): ?̃?  2953 (w), 2946 (w), 2856 (w), 1773 (w), 1731 (s), 1714 (s), 1598 (w), 1495 (w), 1460 (w), 
1354 (w), 1289 (w), 1259 (m), 1134 (w), 1099 (m), 1076 (m), 836 (m) cm-1; 
HRMS (ESI) calcd. for C27H36NO5Si [M+] 482.2357; found 482.2363. 
 
anti-Dimethyl 7-bromo-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (26). 
 
Following the general procedure 6-bromoquinoline (SI-40) (42 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 98 mg (0.19 mmol, 96%) of the title compound 26 were isolated 
as an orange oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.00 (dd, J = 8.6, 2.4 Hz, 1H, ArH), 6.86 (d, J = 2.4 Hz, 1H, ArH), 6.30 (d, J = 8.6 Hz, 1H, ArH), 6.24 – 6.19 
(m, 1H, CH=CH), 6.14 (dd, J = 8.7, 5.9 Hz, 1H, CH-Phth), 5.93 – 5.86 (m, 2H, CH=CH and CH-N), 3.81 (s, 
3H, OCH3), 3.64 (s, 3H, OCH3), 2.96 (dd, J = 13.7, 8.7 Hz, 1H, CH2), 2.52 (dd, J = 13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.8, 168.9, 167.6, 140.7, 134.4, 131.8, 131.5, 129.4, 125.1, 123.5, 
121.8, 121.3, 111.4, 109.9, 67.1, 65.1, 64.3, 52.7, 52.7, 35.1; 
IR (film): ?̃? = 3466 (w), 3058 (w), 2956 (w), 2851 (w), 1772 (w), 1733 (s), 1709 (s), 1490 (m), 1436 (w), 
1396 (w), 1352 (w), 1327 (w), 1266 (s), 1214 (m), 1179 (w), 1156 (w), 1130 (m), 1112 (m), 1087 (m), 
970 (w) cm-1; 
HRMS (ESI) calcd. for C24H18BrN2O6 [M+] 509.0343; found 509.0343. 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-fluoro-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (27). 
 
Following the general procedure 6-fluoroquinoline (SI-59) (29 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 87 mg (0.19 mmol, 97%) of the title compound 27 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.73 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.64 (td, J = 8.6, 3.0 Hz, 1H, ArH), 6.51 (dd, J = 8.6, 3.0 Hz, 1H, ArH), 6.34 (dd, J = 8.9, 4.3 Hz, 1H, ArH), 
6.23 (dd, J = 10.0, 2.1 Hz, 1H, CH=CH), 6.16 (dd, J = 8.6, 5.9 Hz, 1H, CH-Phth), 5.97 – 5.86 (m, 2H, CH-N 
and CH=CH), 3.81 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 2.96 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.52 (dd, J = 
13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.0, 167.7, 155.9 (d, J = 235.5 Hz), 138.1 (d, J = 1.9 Hz), 134.4, 
131.6, 125.4 (d, J = 2.0 Hz), 123.5, 122.3, 120.4 (d, J = 7.5 Hz), 115.1 (d, J = 22.2 Hz), 113.7 (d, J = 23.9 
Hz), 110.3 (d, J = 7.4 Hz), 67.8, 65.4, 64.4, 52.7, 52.7, 35.1; 
19F NMR (376 MHz, CDCl3) δ = -127.77 (td, J = 8.6, 4.3 Hz) ppm. 
IR (film): ?̃? = 2958 (w), 2849 (w), 1773 (w), 1732 (s), 1709 (s), 1498 (s), 1436 (w), 1396 (w), 1352 (w), 
1276 (s), 1246 (s), 1219 (m), 1160 (m), 1111 (m), 1078 (m), 952 (w), 873 (m) cm-1; 
HRMS (ESI) calcd for C24H20FN2O6+ [M+H]+ 451.1300; found 451.1205. 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-phenyl-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (28). 
 
Following the general procedure 6-phenylquinoline (SI-41) (41 mg, 0.20 mmol, 1.00 equiv.), 
cycloproane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 98 mg (0.19 mmol, 96%) of the title compound 28 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.74 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.50 – 7.42 (m, 2H, ArH), 7.35 (t, J = 7.7 Hz, 2H, ArH), 7.25 – 7.19 (m, 2H, ArH), 7.06 (d, J = 2.2 Hz, 1H, 
ArH), 6.52 (d, J = 8.4 Hz, 1H, ArH), 6.39 (dd, J = 10.2, 2.9 Hz, 1H, CH=CH), 6.27 (dd, J = 8.6, 5.9 Hz, 1H, 
CH-Phth), 5.97 (dd, J = 2.9, 1.9 Hz, 1H, CH-N), 5.92 (dd, J = 10.2, 2.9 Hz, 1H, CH=CH), 3.84 (s, 3H, OCH3), 
3.67 (s, 3H, OCH3), 3.02 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.57 (dd, J = 13.7, 5.9 Hz, 1H,CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.1, 167.8, 141.1, 140.7, 134.4, 131.7, 131.0, 128.6, 128.1, 
126.3, 126.2, 126.1, 125.9, 123.5, 120.9, 119.8, 110.1, 67.2, 65.3, 64.5, 52.8, 52.8, 35.4 ppm; 
IR (film): ?̃? 1774 (w), 1732 (s), 1711 (s), 1651 (w), 1609 (w), 1488 (m), 1436 (w), 1395 (w), 1352 (m), 
1327 (m), 1265 (s), 1219 (w), 1180 (w), 1131 (w), 1113 (w), 1077 (m), 1019 (w), 970 (w) cm-1; 
HRMS (ESI) calcd. for C30H25N2O6+ [M+H]+ 509.1707; found 509.1711. 
 
anti-Trimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3,7(3aH)-
tricarboxylate (29). 
 
Following the general procedure methyl quinoline-6-carboxylate (SI-60) (37 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
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(silica, pentane:EtOAc 10:1 to 4:1) and 93 mg (0.19 mmol, 95%) of the title compound 29 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.73 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.64 (dd, J = 8.6, 2.0 Hz, 1H, ArH), 7.44 (d, J = 2.0 Hz, 1H, ArH), 6.43 (d, J = 8.6 Hz, 1H, ArH), 6.33 (dd, J 
= 10.2, 2.0 Hz, 1H, CH=CH), 6.22 (dd, J = 8.7, 6.0 Hz, 1H, CH-Phth), 5.97 – 5.93 (m, 1H, CH-N), 5.89 (dd, 
J = 10.2, 2.9 Hz, 1H, CH=CH), 3.81 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 2.98 (dd, J = 13.7, 
8.7 Hz, 1H, CH2), 2.53 (dd, J = 13.7, 6.0 Hz, 1H, CH2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 169.7, 168.7, 167.5, 166.8, 145.4, 134.5, 131.8, 131.5, 128.5, 125.8, 
123.6, 120.8, 119.5, 119.0, 109.2, 66.5, 64.9, 64.3, 52.8, 52.7, 51.5, 35.1; 
IR (film): ?̃?  2988 (w), 2956 (w), 2902 (w), 1773 (w), 1733 (m), 1708 (s), 1603 (w), 1506 (w), 1432 (w), 
1393 (w), 1353 (w), 1276 (s), 1201 (m), 1151 (w), 1111 (m), 1078 (m) cm-1; 
HRMS (ESI) calcd. for C26H23N2O8+ [M+H]+ 491.1449; found 491.1446. 
 
anti-Dimethyl 7-cyano-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (30). 
 
Following the general procedure methyl quinoline-6-carboxylate (SI-42) (31 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 85 mg (0.19 mmol, 93%) of the title compound 30 were isolated 
as a yellow oil. 
Rf: 0.2 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.74 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.19 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 6.99 (d, J = 2.0 Hz, 1H, ArH), 6.44 (d, J = 8.5 Hz, 1H, CH=CH), 6.30 – 
6.23 (m, 1H, ArH), 6.17 (dd, J = 8.8, 6.0 Hz, 1H, CH-Phth), 5.97 – 5.89 (m, 2H, CH-N and CH=CH), 3.80 (s, 
3H, OCH3), 3.65 (s, 3H, OCH3), 2.97 (dd, J = 13.8, 8.8 Hz, 1H, CH2), 2.54 (dd, J = 13.8, 6.0 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.5, 168.5, 167.4, 144.8, 134.5, 134.0, 131.3, 130.2, 124.8, 123.6, 
122.0, 119.9, 119.6, 109.9, 100.2, 66.1, 64.7, 64.2, 52.8, 52.8, 34.8; 
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IR (film): ?̃?  2956 (w), 2925 (w), 2853 (w), 2215 (m), 1773 (m), 1749 (m), 1731 (s), 1713 (s), 1602 (m), 
1505 (s), 1462 (w), 1393 (w), 1354 (w), 1277 (s), 1240 (m), 1215 (m), 1176 (m), 1146 (m), 1107 (w), 
1089 (m) cm-1; 
HRMS (ESI) calcd. for C26H23N2O8+ [M+H]+ 491.1449; found 491.1446. 
 
anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-9-fluoro-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (31). 
 
Following the general procedure 8-fluoroquinoline (SI-61) (29 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 81 mg (0.18 mmol, 90%) of the title compound 31 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.4, 3.1 Hz, 2H, Phth), 7.71 (dd, J = 5.4, 3.1 Hz, 2H, Phth), 
6.70 (ddd, J = 13.8, 8.1, 1.6 Hz, 1H, ArH), 6.59 (dd, J = 7.5, 1.6 Hz, 1H, ArH), 6.51 (td, J = 7.5, 4.4 Hz, 1H, 
ArH), 6.39 – 6.24 (m, 2H, CH-Phth and CH=CH), 5.96 (dd, J = 10.1, 3.1 Hz, 1H, CH=CH), 5.91 (dd, J = 3.1, 
1.6 Hz, 1H, CH-N), 3.79 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 2.98 (dd, J = 13.8, 8.6 Hz, 1H, CH2), 2.27 (dd, J 
= 13.8, 6.2 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.9, 168.9, 167.5, 150.1 (d, J = 238.3 Hz), 134.0, 131.9, 130.4 (d, J = 
8.7 Hz), 125.5 (d, J = 4.0 Hz), 123.21, 123.15, 123.1 (d, J = 2.2 Hz), 122.5, 119.0 (d, J = 8.1 Hz), 117.1 (d, 
J = 22.9 Hz), 70.5 (s, J = 5.1 Hz), 65.7, 64.8, 52.7, 52.7, 36.2; 
19F NMR (376 MHz, CDCl3) δ = -131.20 (dt, J = 13.8, 3.2 Hz); 
IR (film): ?̃? = 3003 (w), 2955 (w), 2845 (w), 1773 (w), 1732 (s), 1710 (s), 1611 (w), 1475 (m), 1397 (w), 
1353 (m), 1267 (s), 1246 (m), 1219 (m), 1114 (m), 1077 (m) cm-1; 
HRMS (ESI) calcd. for C24H19FN2NaO6+ [M+Na]+ 473.1119; found 473.1124. 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-8-(trifluoromethyl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (32). 
 
Following the general procedure 7-(trifluormethyl)quinoline (SI-62) (39 mg, 0.20 mmol, 1.00 equiv.), 
cyclopropane 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 10:1 to 4:1) and 98 mg (0.20 mmol, 98%) of the title compound 32 were isolated 
as a yellow oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.74 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.85 (d, J = 7.6 Hz, 1H, ArH), 6.79 (dd, J = 7.6, 1.5 Hz, 1H, ArH), 6.72 (s, 1H, ArH), 6.33 (dd, J = 10.0, 1.5 
Hz, 1H, CH=CH), 6.22 (dd, J = 8.7, 5.8 Hz, 1H, CH-Phth), 6.01 – 5.92 (m, 2H, CH-N and CH=CH), 3.83 (s, 
3H, OCH3), 3.65 (s, 3H, OCH3), 2.99 (dd, J = 13.8, 8.7 Hz, 1H, CH2), 2.58 (dd, J = 13.8, 5.8 Hz, 1H, CH2) 
ppm; 
13C NMR (101 MHz, CDCl3): δ = 169.9, 168.9, 167.7, 141.8, 134.5, 131.5, 131.2 (q, J = 31.9 Hz), 127.2, 
125.3, 123.6, 122.9, 122.3, 114.9 (q, J = 3.6 Hz), 106.4 (q, J = 3.5 Hz), 66.9, 65.2, 64.3, 52.8, 52.8, 34.9;22 
19F NMR (376 MHz, CDCl3) δ = -63.1 (s) ppm. 
IR (film): ?̃? = 2959 (w), 2924 (w), 2365 (w), 1772 (w), 1732 (s), 1709 (s), 1509 (w), 1453 (m), 1436 (w), 
1396 (w), 1355 (w), 1327 (w), 1270 (m), 1224 (w), 1143 (w), 1111 (m), 1078 (s), 1046 (w), 1002 (w) 
cm-1; 
HRMS (ESI) calcd for C25H18F3N2O6+ [M+H]+ 499.1111; found 499.1109. 
  
                                                          
22 The CF3 carbon was not observed. 
47 
 
anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-methoxy-6-nitro-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (34). 
 
Following the general procedure 6-methoxy-5-nitroquinoline (SI-44) (41 mg, 0.20 mmol, 1.00 equiv.), 
14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 
(0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 4:1) and 98 mg (0.19 mmol, 97%) of the title compound 34 were isolated as a yellow 
oil. 
Rf: 0.1 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.75 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.66 (d, J = 9.0 Hz, 1H, CH=CH), 6.47 (d, J = 9.0 Hz, 1H, CH=CH), 6.22 – 6.11 (m, 2H, CH-Phth and ArH), 
6.08 (dd, J = 10.5, 3.0 Hz, 1H, ArH), 5.88 (dd, J = 2.9, 2.0 Hz, 1H, CH-N), 3.81 (s, 3H, OCH3), 3.71 (s, 3H, 
OCH3), 3.67 (s, 3H, OCH3), 2.97 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.53 (dd, J = 13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.7, 168.7, 167.7, 142.7, 139.2, 135.9, 134.5, 131.5, 125.7, 123.6, 
118.7, 113.5, 112.3, 111.5, 67.6, 65.1, 63.9, 56.8, 52.9, 35.0; 
IR (film): ?̃?  2957 (w), 2923 (w), 2849 (w), 1771 (w), 1733 (s), 1713 (s), 1532 (m), 1494 (m), 1437 (w), 
1395 (w), 1355 (m), 1329 (w), 1277 (s), 1243 (w), 1222 (w), 1133 (w), 1114 (w), 1077 (m) cm-1; 
HRMS (ESI) calcd. for C25H22N3O9+ [M+H]+ 508.1351; found 508.1367. 
 
anti-Dimethyl 1-(5,6-dichloro-1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (35). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-15 (78 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
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for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 87 mg (0.17 mmol, 87%) of the title compound 35 were isolated as a red oil. 
Rf: 0.2 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ 7.92 (s, 2H, Phth), 6.94 (t, J = 7.7 Hz, 1H, ArH), 6.78 (d, J = 7.1 Hz, 1H, ArH), 
6.57 (t, J = 7.1 Hz, 1H, ArH), 6.32 (dd, J = 12.6, 9.0 Hz, 2H, CH=CH and ArH), 6.18 (dd, J = 8.4, 5.8 Hz, 1H, 
CH-Phth), 5.93 – 5.78 (m, 2H, CH-N and CH=CH), 3.83 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 3.00 (dd, J = 
13.7, 8.4 Hz, 1H, CH2), 2.48 (dd, J = 13.7, 5.8 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.8, 168.9, 165.7, 141.3, 139.2, 130.7, 129.5, 127.2, 126.2, 125.5, 
120.3, 119.4, 118.3, 109.5, 67.8, 65.2, 64.3, 52.8, 52.7, 35.3 ppm; 
IR (film): ?̃?  2955 (w), 1773 (w), 1732 (s), 1708 (s), 1596 (w), 1492 (w), 1437 (w), 1386 (w), 1345 (s), 
1264 (s), 1221 (m), 1134 (w), 1110 (m), 1083 (w), 955 (w), 908 (w) cm-1; 
HRMS (ESI) calcd. for C24H19Cl2N2O6+ [M+H]+ 501.0615; found 501.0615. 
 
anti-Dimethyl 1-(5-nitro-1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (36). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-18 (73 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 2:1) and 85 mg (0.18 mmol, 89%) of the title compound 36 were isolated as a red oil. 
Rf: 0.1 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ 8.62 (d, J = 20.3 Hz, 2H, Phth), 8.04 (d, J = 6.2 Hz, 1H, Phth), 6.92 (t, J = 7.6 
Hz, 1H, ArH), 6.76 (d, J = 7.0 Hz, 1H, ArH), 6.55 (t, J = 7.0 Hz, 1H, ArH), 6.30 (dd, J = 13.6, 8.8 Hz, 2H, ArH 
and CH=CH), 6.26 – 6.16 (m, 1H, CH-Phth), 5.92 – 5.79 (m, 2H, CH-N and CH=CH), 3.84 (s, 3H, OCH3), 
3.64 (s, 3H, OCH3), 3.03 (dd, J = 13.0, 8.1 Hz, 1H, CH2), 2.50 (dd, J = 13.0, 5.8 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.7, 168.8, 165.6, 165.3, 151.7, 141.2, 135.9, 133.0, 129.5, 129.4, 
127.2, 126.1, 124.7, 120.2, 119.4, 118.8, 118.4, 109.5, 68.1, 65.1, 64.3, 52.8, 52.7, 35.3 ppm; 
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IR (film): ?̃?  3007 (w), 2989 (w), 2957 (w), 1780 (w), 1730 (s), 1719 (s), 1599 (w), 1542 (m), 1494 (w), 
1436 (w), 1397 (w), 1340 (m), 1276 (s), 1263 (s), 1221 (w), 1137 (w), 1109 (w), 1079 (w) cm-1; 
HRMS (ESI) calcd. for C24H20N3O8+ [M+H]+ 478.1245; found 478.1242. 
 
anti-Dimethyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (37). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-21 (53 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 71 mg (0.19 mmol, 93%) of the title compound 37 were isolated as a colorless oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 6.96 (td, J = 7.8, 1.6 Hz, 1H, ArH), 6.78 (dd, J = 7.4, 1.6 Hz, 1H, ArH), 6.69 
(s, 2H, Mal), 6.57 (td, J = 7.4, 1.0 Hz, 1H, ArH), 6.39 – 6.22 (m, 2H, CH=CH and ArH), 6.01 (dd, J = 8.6, 
5.9 Hz, 1H, CH-Mal), 5.82 (dd, J = 10.1, 2.9 Hz, 1H, CH=CH), 5.78 (dd, J = 2.9, 1.9 Hz, 1H, CH-N), 3.80 (s, 
3H, OCH3), 3.61 (s, 3H, OCH3), 2.92 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.38 (dd, J = 13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.1, 169.8, 169.0, 141.5, 134.3, 129.5, 127.2, 126.3, 120.3, 119.4, 
118.2, 109.5, 67.0, 65.2, 64.2, 52.7, 52.6, 35.3; 
IR (film): ?̃?  2959 (w), 2901 (w), 1731 (s), 1704 (s), 1651 (w), 1599 (w), 1495 (w), 1460 (w), 1436 (w), 
1406 (w), 1355 (m), 1265 (s), 1221 (w), 1159 (m), 1101 (w), 1081 (m), 1054 (w), 911 (w) cm-1; 
HRMS (ESI) calcd for C20H17N2O6 [M+] 381.1081; found 381.1079. 
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anti-Dimethyl 1-(2,5-dioxopyrrolidin-1-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (38). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-24 (26 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 61 mg (0.16 mmol, 79%) of the title compound 38 were isolated as a colorless oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 6.97 (td, J = 7.8, 1.5 Hz, 1H, ArH), 6.78 (dd, J = 7.4, 1.5 Hz, 1H, ArH), 6.57 
(td, J = 7.4, 0.9 Hz, 1H, ArH), 6.34 – 6.24 (m, 2H, ArH and CH=CH), 6.04 (dd, J = 8.6, 5.9 Hz, 1H, CH-Succ), 
5.84 – 5.76 (m, 2H, CH=CH and CH-N), 3.79 (s, 3H, OCH3), 3.58 (s, 3H, OCH3), 2.84 (dd, J = 13.6, 8.6 Hz, 
1H, CH2), 2.69 (s, 4H, Succ), 2.40 (dd, J = 13.6, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 176.7, 169.9, 169.0, 141.6, 129.5, 127.2, 126.1, 120.4, 119.4, 118.1, 
109.7, 68.2, 65.4, 64.6, 52.7, 52.6, 34.2, 28.1; 
IR (film): ?̃?  2954 (w), 2127 (w), 1732 (s), 1702 (s), 1599 (w), 1496 (w), 1459 (w), 1436 (w), 1398 (w), 
1353 (m), 1310 (w), 1266 (s), 1222 (m), 1176 (s), 1150 (w), 1100 (w), 1085 (m), 1053 (w) cm-1; 
HRMS (ESI) calcd. for C20H20N2NaO6+ [M+Na]+ 407.1214; found 407.1208. 
 
anti-Dimethyl 1-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (39). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-29 (74 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 78 mg (0.16 mmol, 81%) of the title compound 39 were isolated as a yellow oil. 
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Rf: 0.5 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 8.33 (s, 2H, Naphth), 8.05 (dd, J = 6.3, 3.3 Hz, 2H, Naphth), 7.69 (dd, J = 
6.3, 3.3 Hz, 2H, Naphth), 6.96 (td, J = 8.0, 1.6 Hz, 1H, ArH), 6.79 (dd, J = 7.3, 1.6 Hz, 1H, ArH), 6.60 – 
6.51 (m, 1H, ArH), 6.48 (d, J = 8.0 Hz, 1H, ArH), 6.37 – 6.22 (m, 2H, CH-Phth and CH=CH), 6.01 (dd, J = 
2.5 Hz, 1H, CH-N), 5.88 (dd, J = 10.2, 2.5 Hz, 1H, CH=CH), 3.84 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.02 
(dd, J = 13.7, 8.7 Hz, 1H, CH2), 2.60 (dd, J = 13.7, 5.9 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.0, 169.2, 167.4, 141.7, 135.5, 130.3, 129.6, 129.3, 127.3, 127.2, 
126.3, 125.0, 120.5, 119.5, 118.1, 109.9, 67.6, 65.4, 64.5, 52.7, 52.7, 35.2; 
IR (film): ?̃?  2955 (w), 1765 (m), 1731 (s), 1704 (s), 1650 (w), 1600 (w), 1496 (w), 1459 (w), 1339 (s), 
1310 (w), 1265 (s), 1220 (m), 1149 (m), 1136 (m), 1112 (m), 1083 (m) cm-1; 
HRMS (ESI) calcd. for C28H22N2NaO6+ [M+Na]+ 505.1370; found 505.1370. 
 
anti-Dibenzyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (40). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-30 (96 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 107 mg (0.18 mmol, 92%) of the title compound 40 were isolated as a yellow oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.82 (dd, J = 5.4, 3.0 Hz, 2H, Phth), 7.70 (dd, J = 5.4, 3.0 Hz, 2H, Phth), 
7.35 – 7.16 (m, 8H, ArH), 7.10 – 7.01 (m, 2H, ArH), 6.94 (td, J = 7.8, 1.5 Hz, 1H, ArH), 6.72 (dd, J = 7.3, 
1.5 Hz, 1H, ArH), 6.55 (t, J = 7.3 Hz, 1H, ArH), 6.38 (d, J = 10.0 Hz, 1H, CH=CH), 6.19 – 6.10 (m, 2H, CH-
Phth and ArH), 5.99 (t, J = 2.4 Hz, 1H, CH-N), 5.79 (dd, J = 10.0, 2.4 Hz, 1H, CH=CH), 5.22 (m, 2H, CH2Ph), 
5.02 (m, 2H, CH2Ph), 3.00 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.54 (dd, J = 13.7, 5.8 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.4, 168.4, 167.7, 141.5, 135.1, 134.7, 134.3, 131.6, 129.5, 128.5, 
128.4, 128.3, 128.3, 128.2, 128.1, 127.3, 126.3, 123.4, 120.2, 119.4, 118.0, 109.7, 67.6, 67.3, 67.2, 65.4, 
64.5, 35.3 ppm; 
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IR (film): ?̃?  3033 (w), 2960 (w), 1772 (w), 1730 (s), 1712 (s), 1599 (w), 1497 (w), 1459 (w), 1351 (m), 
1265 (s), 1203 (m), 1134 (m), 1072 (m), 909 (s) cm-1; 
HRMS (ESI) calcd. for C36H29N2O6+ [M+H]+ 585.2020; found 585.2018. 
 
anti-bis(2,2,2-Trifluoroethyl) 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (41). 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-31 (92 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 106 mg (0.186 mmol, 93%) of the title compound 41 were isolated as a yellow oil. 
Rf: 0.4 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.86 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.74 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.99 (td, J = 7.9, 1.5 Hz, 1H, ArH), 6.80 (dd, J = 7.4, 1.5 Hz, 1H, ArH), 6.59 (td, J = 7.4, 0.9 Hz, 1H, ArH), 
6.49 (d, J = 7.9 Hz, 1H, ArH), 6.35 (dd, J = 10.2, 2.0 Hz, 1H, CH=CH), 6.27 (dd, J = 8.7, 5.7 Hz, 1H, CH-
Phth), 6.06 (dd, J = 2.9, 2.0 Hz, 1H, CH-N), 5.82 (dd, J = 10.2, 2.9 Hz, 1H, CH=CH), 4.70 – 4.55 (m, 2H, 
CH2CF3), 4.52 – 4.36 (m, 2H, CH2CF3), 3.07 (dd, J = 13.9, 8.7 Hz, 1H, CH2), 2.63 (dd, J = 13.9, 5.7 Hz, 1H, 
CH2); 
13C NMR (101 MHz, CDCl3): δ = 167.7, 167.5, 166.4, 141.1, 134.4, 131.6, 129.8, 127.5, 127.3, 123.6, 
122.5 (q, J = 276.4 Hz), 122.3 (q, J = 277.2 Hz), 119.1, 118.9, 118.5, 109.9, 66.7, 65.0, 64.8, (d, J = 24.9 
Hz), 61.3 (q, J = 37.8 Hz), 61.2 (J = 37.0 Hz), 35.2; 
19F NMR (376 MHz, CDCl3) δ = -73.68 (t, J = 8.4 Hz), -73.74 (t, J = 8.4 Hz); 
IR (film): ?̃?  2976 (w), 2901 (w), 1753 (m), 1712 (s), 1600 (w), 1497 (w), 1461 (w), 1405 (w), 1352 (w), 
1310 (w), 1276 (m), 1236 (w), 1166 (s), 1132 (m), 1110 (m), 1087 (m), 977 (w) cm-1; 
HRMS (ESI) calcd. for C26H18F6N2NaO6+ [M+Na]+ 591.0961; found 591.0962. 
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rac-(1R,3S,3aR)-3-tert-Butyl 3-methyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-
a]quinoline-3,3(3aH)-dicarboxylate (42a) and rac-(1R,3R,3aR)-3-tert-Butyl 3-methyl 1-(1,3-
dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (42b) 
 
Following the general procedure quinoline (8) (26 mg, 0.20 mmol, 1.00 equiv.), SI-32 (73 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) affording 42a (53 mg, 0.11 mmol, 56%) and 42b (15 mg, 0.05 mmol, 16%) as yellow oils.23 
 
42a 
Rf: 0.51 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.95 (td, J =8.0, 1.6 Hz, 1H, ArH), 6.78 (dd, J = 7.3, 1.6 Hz, 1H, ArH), 6.55 (td, J = 7.3, 1.0 Hz, 1H, ArH), 
6.41 (d, J = 8.1 Hz, 1H, ArH), 6.33 – 6.26 (m, 1H, CH=CH), 6.11 (dd, J = 8.6, 6.1 Hz, 1H, CH-Phth), 5.98 – 
5.82 (m, 2H, CH-N and CH=CH), 3.81 (s, 3H, OCH3), 2.88 (dd, J = 13.7, 8.6 Hz, 1H, CH2), 2.51 (dd, J = 13.7, 
6.1 Hz, 1H, CH2), 1.25 (s, 9H, C(CH3)3); 
13C NMR (101 MHz, CDCl3): 169.4, 168.6, 167.7, 142.2, 134.3, 131.7, 129.5, 127.1, 126.4, 123.4, 120.5, 
119.6, 118.0, 109.7, 83.0, 68.1, 66.1, 64.2, 52.5, 35.2, 27.6; 
IR (film): ?̃?  2981 (w), 1772 (w), 1710 (s), 1600 (w), 1496 (w), 1459 (w), 1394 (w), 1367 (w), 1263 (s), 
1227 (w), 1151 (m), 1134 (m), 1078 (m), 1050 (w) cm-1; 
HRMS (ESI) calcd. for C27H27N2O6+ [M+H]+ 475.1864; found 475.1872. 
  
                                                          
23 The minor diasteroisomer 30b slowly converts into the major diastereoisomer 30a in CDCl3. 
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42b 
Rf: 0.49 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.86 (dd, J = 5.6, 3.3 Hz, 2H, Phth), 7.73 (dd, J = 5.6, 3.3 Hz, 2H, Phth), 
6.95 (t, J = 7.9 Hz, 1H, ArH), 6.77 (d, J = 7.2 Hz, 1H, ArH), 6.54 (t, J = 7.2 Hz, 1H, ArH), 6.40 (d, J = 7.9 Hz, 
1H, ArH), 6.28 (d, J = 10.1 Hz, 1H, CH=CH), 6.19 (dd, J = 8.2, 6.5 Hz, 1H, CH-Phth), 5.95 – 5.79 (m, 2H, 
CH-N and CH=CH), 3.64 (s, 3H, OCH3), 2.94 (dd, J = 13.7, 8.2 Hz, 1H, CH2), 2.50 (dd, J = 13.7, 6.5 Hz, 1H, 
CH2), 1.51 (s, 9H, C(CH3)3); 
13C NMR (101 MHz, CDCl3): 170.5, 167.7, 167.7, 141.8, 134.3, 131.8, 129.5, 127.1, 126.1, 123.5, 120.9, 
119.5, 117.9, 109.7, 82.4, 67.3, 66.1, 64.3, 52.4, 35.5, 27.9 ppm; 
IR (film): ?̃?  2981 (w), 1777 (w), 1726 (s), 1714 (s), 1600 (w), 1497 (w), 1459 (w), 1395 (w), 1354 (w), 
1276 (m), 1262 (m), 1219 (w), 1149 (w), 1135 (m), 1112 (w), 1050 (w), 844 (w) cm-1; 
HRMS (ESI) calcd. for C27H27N2O6+ [M+H]+ 475.1864; found 475.1868. 
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9. Scope of the reaction with isoquinolines 
 
anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-1,1(10bH)-
dicarboxylate (43). 
 
Following the general procedure isoquinoline (SI-63) (26 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 72 mg (0.17 mmol, 83%) of the title compound 43 were isolated as a yellow oil. 
Rf: 0.2 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.86 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.73 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.55 – 7.50 (m, 1H, ArH), 7.09 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.01 (td, J = 7.5, 1.5 Hz, 1H, ArH), 6.80 (dd, 
J = 7.5, 1.5 Hz, 1H, ArH), 6.16 (d, J = 7.6 Hz, 1H, CH=CH-N), 6.10 (s, 1H, CH-N), 6.07 (dd, J = 9.0, 5.3 Hz, 
1H, CH-Phth), 5.12 (d, J = 7.6 Hz, 1H, N-CH=CH), 3.86 (s, 3H, OCH3), 3.35 (s, 3H, OCH3), 3.02 (dd, J = 13.7, 
9.0 Hz, 1H, CH2), 2.85 (dd, J = 13.7, 5.3 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.6, 170.0, 168.1, 134.4, 134.3, 131.9, 131.8, 128.1, 127.8, 127.0, 
125.3, 123.9, 123.6, 98.4, 69.6, 67.7, 64.9, 52.8, 52.5, 34.2; 
IR (film): ?̃?  2960 (w), 2358 (w), 1774 (w), 1731 (s), 1714 (s), 1635 (w), 1462 (w), 1436 (w), 1371 (w), 
1356 (w), 1329 (w), 1271 (w), 1214 (w), 1141 (w), 1093 (w), 1062 (w), 914 (w) cm-1; 
HRMS (ESI) calcd. for C24H21N2O6+ [M+H]+ 433.1394; found 433.1404. 
 
anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-
1,1(10bH)-dicarboxylate (44). 
 
Following the general procedure isoquinoline-4-carbonitrile (SI-46) (31 mg, 0.20 mmol, 1.00 equiv.), 
14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 
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(0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 3:1) and 83 mg (0.18 mmol, 91%) of the title compound 44 were isolated as a yellow 
oil. 
Rf: 0.1 (silica, pentane:EtOAc 3:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.77 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.56 (d, J = 7.7 Hz, 1H, ArH), 7.25 – 7.15 (m, 2H, ArH), 7.15 – 7.07 (m, 1H, ArH), 6.98 (s, 1H, C=CH-N), 
6.16 (s, 1H, CH-N), 6.11 (dd, J = 8.9, 5.2 Hz, 1H, CH-Phth), 3.89 (s, 3H, OCH3), 3.37 (s, 3H, OCH3), 3.03 
(dd, J = 14.1, 8.9 Hz, 1H, CH2), 2.93 (dd, J = 14.1, 5.2 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.7, 169.5, 167.6, 143.7, 134.7, 131.3, 128.8, 127.6, 126.9, 126.8, 
124.7, 123.8, 122.4, 118.2, 82.3, 67.4, 67.0, 63.9, 53.1, 52.7, 34.0; 
IR (film): ?̃?  2956 (w), 2251 (w), 2207 (m), 1835 (w), 1776 (w), 1730 (s), 1730 (s), 1713 (s), 1623 (s), 1571 
(w), 1497 (w), 1457 (m), 1436 (w), 1366 (m), 1353 (m), 1327 (m), 1272 (m), 1206 (m), 1117 (m), 1092 
(m), 1064 (m), 910 (s) cm-1; 
HRMS (ESI) calcd. for C25H20N3O6+ [M+H]+ 458.1347; found 458.1346. 
 
anti-Trimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-1,1,6(10bH)-
tricarboxylate (45). 
 
Following the general procedure methyl isoquinoline-4-carboxylate (SI-48) (37 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred 
in CH2Cl2 (0.4 mL, 0.5 M) for 16 hours. The crude product was purified by column chromatography 
(silica, pentane:EtOAc 4:1 to 2:1) and 87 mg (0.18 mmol, 89%) of the title compound 45 were isolated 
as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 8.30 (dd, J = 8.1, 1.4 Hz, 1H, ArH), 7.85 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.73 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.54 (d, J = 7.7 Hz, 1H, ArH), 7.50 (s, 1H, CH=C(COOCH3)), 7.17 (td, J 
= 7.7, 1.4 Hz, 1H, ArH), 7.05 (td, J = 7.7, 1.4 Hz, 1H, ArH), 6.19 – 6.11 (m, 2H, Ar-CH-N and CH-Phth), 
3.87 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 3.32 (s, 3H, OCH3), 3.03 (dd, J = 13.9, 9.0 Hz, 1H, CH2), 2.87 (dd, J 
= 13.9, 5.3 Hz, 1H, CH2); 
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13C NMR (101 MHz, CDCl3): δ = 169.9, 169.5, 167.6, 166.2, 144.4, 134.6, 131.4, 128.7, 128.2, 127.2, 
125.5, 125.4, 123.8, 123.7, 98.5, 68.0, 67.0, 64.3, 52.9, 52.6, 50.7, 34.3; 
IR (film): ?̃?  3499 (w), 2938 (w), 2830 (w), 1738 (s), 1636 (s), 1417 (m), 1298 (m), 1246 (m), 1176 (m), 
1157 (m), 940 (s) cm-1; 
HRMS (ESI) calcd. for C26H23N2O8+ [M+H]+ 491.1449; found 491.1449. 
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10. Scope of the reaction with benzo- thia/oxa-zole 
 
anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydrobenzo[d]pyrrolo[2,1-b]thiazole-3,3(3aH)-
dicarboxylate (46). 
 
Following the general procedure benzothiazole (SI-64) (27 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 83 mg (0.19 mmol, 95%) of the title compound 46 were isolated as a colorless oil. 
Rf: 0.6 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.4, 3.1 Hz, 2H, Phth), 7.75 (dd, J = 5.4, 3.1 Hz, 2H, Phth), 
6.94 (ddd, J = 9.0, 7.9, 1.2 Hz, 2H, ArH), 6.71 (td, J = 7.5, 1.2 Hz, 1H, ArH), 6.65 (d, J = 7.8 Hz, 1H, CH-
Phth), 6.30 (s, 1H, S-CH-N), 6.20 (t, J = 7.9 Hz, 1H, ArH), 3.85 (s, 3H, OCH3), 3.45 (s, 3H, OCH3), 2.95 (d, J 
= 7.8 Hz, 2H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.4, 168.8, 167.6, 147.1, 134.4, 131.6 (3C overlapping, two of them 
symmetric), 125.6, 123.5, 121.2, 120.9, 109.2, 74.1, 69.9, 66.7, 53.0, 52.5, 35.0; 
IR (film): ?̃?  2956 (w), 2364 (w), 2257 (w), 1773 (w), 1748 (m), 1724 (m), 1716 (s), 1583 (w), 1472 (m), 
1393 (w), 1364 (m), 1350 (m), 1333 (m), 1297 (m), 1273 (m), 1220 (w), 1131 (m), 1070 (w), 1036 (w), 
971 (w), 907 (s) cm-1; 
HRMS (ESI) calcd. for C22H18N2NaO6S+ [M+Na]+ 461.0778; found 461.0773. 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydrobenzo[d]pyrrolo[2,1-b]oxazole-3,3(3aH)-
dicarboxylate (47). 
 
Following the general procedure benzoxazole (SI-65) (24 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (6 mg, 0.01 mmol, 5 mol%) were stirred in CH2Cl2 (0.4 mL, 0.5 M) 
for 16 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 
to 4:1) and 62 mg (0.15 mmol, 73%) of the title compound 47 were isolated as a colorless oil. 
Rf: 0.5 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.89 (dd, J = 5.3, 3.0 Hz, 2H, Phth), 7.77 (dd, J = 5.3, 3.0 Hz, 2H, Phth), 
6.79 (pd, J = 7.5, 1.4 Hz, 2H, ArH), 6.75 – 6.67 (m, 3H, O-CH-N and ArH), 6.09 (dd, J = 8.4, 6.8 Hz, 1H, 
CH-Phth), 3.92 (s, 3H, OCH3), 3.53 (s, 3H, OCH3), 3.12 – 2.95 (m, 2H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 168.8, 168.3, 167.5, 149.8, 138.4, 134.4, 131.7, 123.6, 122.2, 121.9, 
110.5, 108.0, 101.7, 70.5, 65.8, 53.3, 53.1, 34.3 ppm; 
IR (film): ?̃?  2957 (w), 1737 (s), 1720 (s), 1487 (m), 1437 (w), 1363 (m), 1279 (m), 1252 (s), 1127 (m), 
1054 (w), 898 (w) cm-1; 
HRMS (ESI) calcd. for C22H19N2O7+ [M+H]+ 423.1187; found 423.1179. 
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11. Scope of the reaction with pyridines 
 
anti-Dimethyl 7-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(48). 
 
Following the general procedure isonicotinonitrile (SI-66) (21 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 1 M) 
for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 10:1 to 
3:1) and 61 mg (0.15 mmol, 75%) of the title compound 48 were isolated as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 3:1); 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.76 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.08 (dt, J = 7.5, 0.7 Hz, 1H, CH=CHN), 6.04 – 5.92 (m, 2H, N-CH-Phth and C=CH-CHN), 5.64 (d, J = 3.4 
Hz, 1H, CH-N), 4.52 (dd, J = 7.4, 1.6 Hz, 1H, CH=CHN), 3.82 (s, 6H, 2 OCH3), 2.80 (dd, J = 13.8, 8.5 Hz, 1H, 
CH2), 2.64 (dd, J = 13.9, 6.1 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.8, 168.4, 167.8, 134.6, 134.6, 131.5, 125.8, 123.7, 117.5, 111.6, 
91.7, 68.0, 66.7, 63.3, 53.2, 53.0, 32.1 ppm; 
IR (film): ?̃?  2958 (w), 2226 (w), 1775 (w), 1732 (s), 1712 (s), 1633 (w), 1572 (w), 1436 (w), 1354 (w), 
1328 (w), 1271 (m), 1218 (w), 1130 (w), 1088 (w), 972 (w) cm-1; 
HRMS (ESI) calcd. for C21H16N3O6 [M+] 406.1034; found 406.1036. 
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anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(49). 
 
Following the general procedure nicotinonitrile (SI-67) (104 mg, 1.00 mmol, 1.00 equiv.), 14 (318 mg, 
1.05 mmol, 1.05 equiv.) and Yb(OTf)3 (62 mg, 0.10 mmol, 10 mol%) were stirred in CH2Cl2 (1.0 mL, 1 M) 
for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 4:1 to 
2:1) and 280 mg (0.69 mmol, 69%) of the title compound 49 were isolated as a yellow oil. 
Performing the reaction with SI-67 (21 mg, 0.20 mmol), 14 (64 mg, 0.21 mmol) and Yb(OTf)3 (12 mg, 
20 µmol) afforded 58 mg (0.14 mmol, 71%) of the title compound 49. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.78 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.76 (t, J = 1.2 Hz, 1H, C=CH-N), 6.07 (dd, J = 8.6, 6.3 Hz, 1H, CH-NPhth), 5.81 (dt, J = 10.3, 1.7 Hz, 1H, 
CH=CH-CHN), 5.57 (t, J = 2.2 Hz, 1H, N-CH-CH=CH), 5.37 (ddd, J = 10.2, 2.4, 1.0 Hz, 1H, CH=CH-CHN), 
3.82 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 2.82 (dd, J = 14.0, 8.6 Hz, 1H, CH2), 2.72 (dd, J = 13.9, 6.3 Hz, 1H, 
CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.7, 168.4, 167.5, 143.8, 134.8, 131.3, 123.9, 121.4, 119.7, 113.9, 
79.4, 67.2, 66.0, 62.7, 53.1, 53.0, 32.1 ppm; 
IR (film): ?̃?  3007 (w), 2956 (w), 2257 (w), 2203 (m), 1776 (w), 1713 (s), 1644 (m), 1577 (m), 1435 (w), 
1394 (w), 1353 (m), 1332 (m), 1273 (s), 1226 (m), 1128 (m), 1100 (m), 981 (w), 910 (m) cm-1; 
HRMS (ESI) calcd. for C21H18N3O6+ [M+H]+ 408.1190; found 408.1186. 
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anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-7-methyl-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (50). 
 
Following the general procedure 3-cyano-4-methylpyridine (SI-68) (24 mg, 0.20 mmol, 1.00 equiv.), 14 
(64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 
1 M) for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 3:1 
to 2:1) and 63 mg (0.15 mmol, 75%) of the title compound 50 were isolated as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.77 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.78 (s, 1H, CH=C(CN)), 6.06 (dd, J = 8.6, 6.2 Hz, 1H, N-CH-Phth), 5.51 (t, J = 2.0 Hz, 1H, N-CH-CH=C(CH3)), 
5.18 – 5.11 (m, 1H, CH=C(CH3)), 3.81 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 2.81 (dd, J = 14.0, 8.6 Hz, 1H, 
CH2), 2.71 (dd, J = 14.0, 6.2 Hz, 1H, CH2), 1.80 (t, J = 1.6 Hz, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ = 169.8, 168.6, 167.5, 144.0, 134.7, 131.4, 128.4, 123.8, 119.1, 109.4, 
82.4, 67.1, 66.0, 63.5, 53.0, 52.9, 32.2, 19.4; 
IR (film): ?̃?  3056 (w), 2956 (w), 2202 (w), 1777 (w), 1718 (s), 1660 (w), 1585 (w), 1436 (w), 1351 (w), 
1329 (w), 1266 (s), 1130 (w), 1092 (m), 909 (s) cm-1; 
HRMS (ESI) calcd. for C22H19N3NaO6+ [M+Na]+ 444.1166; found 444.1165. 
 
anti-Dimethyl 7-bromo-6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (51). 
 
Following the general procedure 4-bromopyridine-3-carbonitrile (SI-49) (37 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred 
in CH2Cl2 (0.2 mL, 1 M) for 3 hours. The crude product was purified by column chromatography (silica, 
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pentane:EtOAc 4:1 to 2:1) and 68 mg (0.14 mmol, 70%) of the title compound 51 were isolated as a 
yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.79 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.81 (s, 1H, N-CH=C(CN)), 6.08 (dd, J = 8.6, 6.3 Hz, 1H, N-CH-Phth), 5.70 (d, J = 2.5 Hz, 1H, C(Br)=CH), 
5.58 (d, J = 2.5 Hz, 1H, N-CH-CH=C(Br)), 3.83 (s, 6H, OCH3), 2.84 (dd, J = 14.0, 8.6 Hz, 1H, CH2), 2.73 (dd, 
J = 13.9, 6.3 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.3, 168.0, 167.3, 144.8, 134.9, 131.2, 124.0, 117.9, 114.3, 113.1, 
83.5, 66.8, 65.7, 65.1, 53.4, 53.2, 32.1 ppm; 
IR (film): ?̃?  2956 (w), 2208 (w), 1730 (s), 1712 (s), 1626 (m), 1577 (m), 1434 (w), 1351 (m), 1273 (s), 
1133 (m), 1103 (m), 1001 (m), 912 (m) cm-1; 
HRMS (ESI) calcd. for C21H15BrN3O6+ [M+H]+ 484.0139; found 484.0130. 
 
anti-Dimethyl 7-(5-((tert-butyldimethylsilyl)oxy)pentyl)-6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-
dihydroindolizine-1,1(8aH)-dicarboxylate (52). 
 
Following the general procedure SI-52 (61 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 0.21 mmol, 
1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 1 M) for 3 hours. 
The crude product was purified by column chromatography (silica, pentane:EtOAc 3:1 to 2:1) and 
88 mg (0.15 mmol, 72%) of the title compound 52 were isolated as a yellow oil containing minor 
impurities which could not be removed. 
Rf: 0.5 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.78 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
6.79 (s, 1H, N-CH=C(CN)), 6.07 (dd, J = 8.6, 6.3 Hz, 1H, CHPthth), 5.55 (dt, J = 2.4, 1.3 Hz, 1H, CH-CH-N), 
5.12 (dd, J = 2.4, 1.3 Hz, 1H, N-CH-CH), 3.83 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.59 (t, J = 6.6 Hz, 2H, CH2-
OTBS), 2.82 (dd, J = 14.1, 8.6 Hz, 1H, CH2-CHPhth), 2.73 (dd, J = 14.1, 6.3 Hz, 1H, CH2-CHPhth), 2.09 (t, 
J = 7.6 Hz, 2H, C-CH2), 1.56 – 1.40 (m, 4H, 2x CH2), 1.34 (m, 2H, CH2), 0.87 (s, 9H, C(CH3)3), 0.03 (s, 6H, 
Si(CH3)2); 
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13C NMR (101 MHz, CDCl3): δ = 169.8, 168.6, 167.5, 144.4, 134.8, 132.8, 131.4, 123.9, 119.1, 109.0, 
82.1, 67.2, 66.1, 63.5, 63.1, 53.0 (2 C), 33.3, 32.6, 32.3, 28.2, 26.0, 25.3, 18.3, -5.3; 
IR (film): ?̃?  2953 (w), 2931 (w), 2857 (w), 2202 (w), 1777 (w), 1716 (s), 1602 (w), 1470 (w), 1436 (w), 
1394 (w), 1351 (w), 1327 (w), 1273 (w), 1217 (w), 1099 (m), 912 (m), 836 (m) cm-1; 
HRMS (ESI) calcd. for C32H42N3O7Si+ [M+H]+ 608.2787; found 608.2767. 
 
anti-6,7-Diethyl 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6,7(8aH)-
tetracarboxylate (54). 
 
Following the general procedure dietyl pyridine-3,4-dicarboxylate (SI-69) (45 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred 
in CH2Cl2 (0.2 mL, 1 M) for 3 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 4:1 to 2:1) and 78 mg (0.15 mmol, 74%) of the title compound 54 were isolated as a 
yellow oil. 
Rf: 0.2 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.77 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.19 (s, 1H, N-CH=C(COOEt)), 6.12 (dd, J = 8.6, 6.3 Hz, 1H, CH-Phth), 5.67 – 5.54 (m, 2H, N-CH-CH and 
N-CH-CH=C(COOEt)), 4.20 (qd, J = 7.1, 4.0 Hz, 2H, OCH2), 4.06 (qd, J = 7.1, 2.5 Hz, 2H, OCH2), 3.81 (s, 
3H, OCH3), 3.78 (s, 3H, OCH3), 2.86 (dd, J = 13.9, 8.6 Hz, 1H, CH2), 2.65 (dd, J = 13.9, 6.3 Hz, 1H, CH2), 
1.26 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.17 (t, J = 7.1 Hz, 3H, OCH2CH3); 
13C NMR (101 MHz, CDCl3): δ = 169.5, 168.3, 168.0, 167.4, 164.6, 142.9, 134.7, 131.4, 130.6, 123.8, 
114.6, 97.9, 67.1, 65.6, 63.0, 61.0, 59.7, 53.1, 53.0, 32.6, 14.3, 14.0 ppm; 
IR (film): ?̃?  2999 (w), 2968 (w), 2238 (w), 1786 (w), 1742 (s), 1702 (s), 1653 (w), 1557 (m), 1459 (m), 
1342 (m), 1283 (s), 1166 (s), 1082 (s), 1043 (m), 982 (w), 934 (m) cm-1; 
HRMS (ESI) calcd. for C26H27N2O10+ [M+H]+ 527.1660; found 527.1669. 
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anti-6,8-Diethyl 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6,8(8aH)-
tetracarboxylate (55). 
 
Following the general procedure dietyl pyridine-3,5-dicarboxylate (SI-70) (45 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred 
in CH2Cl2 (0.2 mL, 1 M) for 3 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 4:1 to 2:1) and 82 mg (0.16 mmol, 78%) of the title compound 55 were isolated as a 
yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.77 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.42 (t, J = 1.4 Hz, 1H, N-CH=C(COOEt)), 7.30 (d, J = 1.4 Hz, 1H, (COOEt)C-CH=C(COOEt)), 6.09 (d, J = 1.4 
Hz, 1H, N-CH-C(COOEt)), 5.98 (dd, J = 8.1 Hz, 1H, CH-Phth), 4.28 – 4.00 (m, 4H, 2xOCH2), 3.83 (s, 3H, 
OCH3), 3.75 (s, 3H, OCH3), 2.97 (m, 2H, CH2), 1.27 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.20 (t, J = 7.1 Hz, 3H, 
OCH2CH3); 
13C NMR (101 MHz, CDCl3): δ = 168.8, 167.9, 167.0, 165.2, 165.0, 145.6, 134.7, 131.7, 131.4, 123.8, 
114.4, 99.0, 66.4, 65.7, 65.4, 60.2, 59.8, 52.9, 35.0, 14.4, 14.2 
IR (film): ?̃?  2983 (w), 2956 (w), 2261 (w), 1779 (w), 1718 (s), 1687 (s), 1634 (m), 1557 (m), 1435 (w), 
1368 (w), 1330 (m), 1270 (m), 1225 (s), 1131 (s), 1089 (m), 1023 (w), 910 (s) cm-1; 
HRMS (ESI) calcd. for C26H27N2O10+ [M+H]+ 527.1660; found 527.1642. 
 
anti-6-(1,1,1,3,3,3-Hexafluoropropan-2-yl) 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-
dihydroindolizine-1,1,6(8aH)-tricarboxylate (56). 
 
Following the general procedure 1,1,1,3,3,3-hexafluoropropan-2-yl nicotinate (SI-54) (55 mg, 
0.20 mmol, 1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) 
were stirred in CH2Cl2 (0.2 mL, 1 M) for 3 hours. The crude product was purified by column 
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chromatography (silica, pentane:EtOAc 5:1 to 4:1) and 84 mg (0.15 mmol, 73%) of the title compound 
56 were isolated as a yellow oil. 
Rf: 0.5 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.89 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.78 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.38 (s, 1H, (COOR)C=CH-N), 6.32 (dt, J = 10.5, 1.8 Hz, 1H, CH=CH-C(COOR)), 6.17 (dd, J = 8.7, 6.2 Hz, 
1H, N-CH-Phth), 5.81 (quint, J = 6.3 Hz, 1H, CH(CCF3)2), 5.65 (t, J = 2.2 Hz, 1H, N-CH), 5.39 (dd, J = 10.5, 
2.2 Hz, 1H, N-CH-CH=CH), 3.84 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.88 (dd, J = 14.0, 8.7 Hz, 1H, CH2), 
2.72 (dd, J = 14.0, 6.2 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.6, 168.4, 167.4, 161.9, 145.3, 134.8, 131.4, 123.9, 121.5, 120.7 (q, 
J = 282.9 Hz), 112.3, 95.8, 67.1, 65.6, 65.5 (quint, J = 34.5 Hz), 63.4, 53.1, 53.0, 32.6; 
19F NMR (376 MHz, CDCl3): δ = –73.3 – –73.4 (m); 
IR (film): ?̃?  2958 (w), 2259 (w), 1715 (s), 1638 (w), 1574 (m), 1436 (w), 1352 (m), 1274 (m), 1195 (m), 
1099 (s), 982 (w), 907 (s) cm-1; 
HRMS (ESI) calcd. for C24H18F6N2NaO8+ [M+Na]+ 599.0860; found 599.0850. 
 
anti-Trimethyl 3-(1,3-dioxoisoindolin-2-yl)-7-(trifluoromethyl)-2,3-dihydroindolizine-1,1,6(8aH)-
tricarboxylate (57). 
 
Following the general procedure methyl 4-(trifluormethyl)nicotinate (SI-71) (41 mg, 0.20 mmol, 
1.00 equiv.), 14 (64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred 
in CH2Cl2 (0.2 mL, 1 M) for 3 hours. The crude product was purified by column chromatography (silica, 
pentane:EtOAc 4:1 to 2:1) and 75 mg (0.15 mmol, 74%) of the title compound 57 were isolated as a 
yellow oil. 
Rf: 0.4 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.79 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
7.36 (s, 1H, N-CH=C(COOMe)), 6.14 (dd, J = 8.6, 6.3 Hz, 1H, N-CH-Phth), 5.97 (s, 1H, CH=C(CF3)), 5.67 
(dd, J = 2.7 Hz, 1H, N-CH-CH=C(CF3)), 3.84 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.62 (s, 3H, OCH3), 2.89 (dd, 
J = 13.9, 8.6 Hz, 1H, CH2), 2.68 (dd, J = 13.9, 6.3 Hz, 1H, CH2); 
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13C NMR (101 MHz, CDCl3): δ = 169.2, 168.1, 167.4, 163.9, 145.1, 134.8, 131.4, 126.0 (q, J = 32.2 Hz), 
123.9, 116.6 (q, J = 7.8 Hz), 95.2, 67.1, 65.7, 62.6, 53.2, 53.1, 51.0, 32.6; 24 
19F NMR (376 MHz, CDCl3): δ = –63.3 (s); 
IR (film): ?̃?  2956 (w), 2372 (w), 2350 (m), 1713 (s), 1642 (w), 1572 (m), 1436 (m), 1354 (m), 1326 (m), 
1289 (m), 1222 (w), 1142 (s), 1089 (m), 1013 (m), 916 (m) cm-1; 
HRMS (ESI) calcd. for C23H20F3N2O8+ [M+H]+ 509.1166; found 509.1136. 
 
anti-Trimethyl 7-chloro-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6(8aH)-tricarboxylate 
(58). 
 
Following the general procedure methyl 4-chloronicotinate (SI-56) (34 mg, 0.20 mmol, 1.00 equiv.), 14 
(64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 
1 M) for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 4:1 
to 2:1) and 72 mg (0.15 mmol, 76%) of the title compound 58 were isolated as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.88 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.79 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.33 (s, 1H, N-CH=C(COOCH3)), 6.13 (dd, J = 8.7, 6.3 Hz, 1H, CH-Phth), 5.63 (d, J = 2.7 Hz, 1H, CH=CCl), 
5.46 (d, J = 2.7 Hz, 1H, N-CH-CH), 3.83 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.62 (s, 3H, OCH3), 2.86 (dd, J = 
13.9, 8.7 Hz, 1H, CH2), 2.68 (dd, J = 13.9, 6.3 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.6, 168.3, 167.4, 164.1, 144.8, 134.8, 131.4, 127.6, 123.9, 111.3, 
97.3, 67.1, 65.8, 64.8, 53.3, 53.1, 50.9, 32.7; 
IR (film): ?̃?  2955 (w), 1777 (w), 1732 (s), 1715 (s), 1626 (w), 1566 (w), 1435 (w), 1354 (m), 1327 (m), 
1263 (m), 1149 (m), 1016 (w), 917 (w) cm-1; 
HRMS (ESI) calcd. for C22H20ClN2O8+ [M+H]+ 475.0903; found 475.0900. 
  
                                                          
24 The CF3 carbon was not observed. 
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anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-6-nitro-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(59). 
 
Following the general procedure 3-nitropyridine (SI-72) (25 mg, 0.20 mmol, 1.00 equiv.), 14 (64 mg, 
0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 1 M) 
for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 4:1 to 
2:1) and 65 mg (0.15 mmol, 76%) of the title compound 59 were isolated as a red oil. 
Rf: 0.2 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.90 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.87 (d, J = 1.7 Hz, 1H, C=CHN), 7.81 
(dd, J = 5.5, 3.1 Hz, 2H, Phth), 6.72 (dt, J = 10.8, 2.1 Hz, 1H, NCH=CH=CH), 6.22 (dd, J = 8.6, 6.7 Hz, 1H, 
CH-NPhth), 5.67 (t, J = 2.1 Hz, 1H, NCH-CH=CH), 5.43 (dd, J = 10.8, 2.1 Hz, 1H, NCH-CH=CH), 3.85 (s, 3H, 
OCH3), 3.79 (s, 3H, OCH3), 2.91 (dd, J = 13.9, 8.6 Hz, 1H, CH2), 2.79 (dd, J = 13.9, 6.7 Hz, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.2, 168.0, 167.2, 141.6, 135.0, 131.2, 124.4, 124.0, 119.3, 112.5, 
66.8, 65.0, 63.9, 53.3, 53.2, 32.7 ppm; 
IR (film): ?̃?  2958 (w), 1780 (w), 1715 (s), 1635 (m), 1577 (m), 1549 (w), 1490 (w), 1435 (w), 1361 (w), 
1267 (m), 1223 (m), 1181 (s), 1131 (w), 1085 (s), 982 (w) cm-1; 
HRMS (ESI) calcd. for C20H18N3O8+ [M+H]+ 428.1088; found 428.1092. 
 
anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-7-methyl-6-nitro-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (60). 
 
Following the general procedure 4-methyl-3-nitropyridine (SI-73) (28 mg, 0.20 mmol, 1.00 equiv.), 14 
(64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 
1 M) for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 3:1 
to 2:1) and 65 mg (0.15 mmol, 74%) of the title compound 60 were isolated as a red oil. 
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Rf: 0.2 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.96 (s, 1H, C=CH-N), 7.89 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.80 (dd, J = 5.5, 
3.0 Hz, 2H, Phth), 6.21 (dd, J = 8.5, 6.8 Hz, 1H, N-CH-Phth), 5.58 (t, J = 2.0 Hz, 1H, N-CH-CH), 5.12 (t, J = 
1.7 Hz, 1H, (CH3)C=CH), 3.84 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.88 (dd, J = 13.9, 8.5 Hz, 1H, CH2), 2.75 
(dd, J = 13.9, 6.8 Hz, 1H, CH2), 2.15 (t, J = 1.7 Hz, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ = 169.3, 168.2, 167.1, 143.2, 134.9, 131.3, 129.2, 125.9, 124.0, 110.5, 
66.8, 65.1, 64.1, 53.2, 53.1, 32.8, 21.5; 
IR (film): ?̃?  2957 (w), 1778 (w), 1715 (s), 1671 (m), 1640 (m), 1571 (m), 1497 (w), 1434 (w), 1359 (w), 
1265 (s), 1234 (m), 1169 (s), 1079 (s), 1041 (m), 942 (w) cm-1; 
HRMS (ESI) calcd. for C21H20N3O8+ [M+H]+ 442.1245; found 442.1241. 
 
anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-5-methyl-6-nitro-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (61). 
 
Following the general procedure 2-methyl-3-nitropyridine (SI-74) (28 mg, 0.20 mmol, 1.00 equiv.), 14 
(64 mg, 0.21 mmol, 1.05 equiv.) and Yb(OTf)3 (12 mg, 20 µmol, 10 mol%) were stirred in CH2Cl2 (0.2 mL, 
1 M) for 3 hours. The crude product was purified by column chromatography (silica, pentane:EtOAc 3:1 
to 2:1) and 71 mg (0.15 mmol, 80%) of the title compound 61 were isolated as a yellow oil. 
Rf: 0.3 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.79 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.84 (dd, J = 10.7, 2.3 Hz, 1H, CH-C(NO2)), 6.42 (dd, J = 8.5, 6.8 Hz, 1H, CH-Phth), 5.77 (t, J = 2.3 Hz, 1H, 
N-CH-CH), 5.40 (dd, J = 10.7, 2.3 Hz, 1H, n-CH-CH=CH), 3.80 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 2.95 (dd, 
J = 13.7, 8.5 Hz, 1H, CH2), 2.50 (dd, J = 13.7, 6.8 Hz, 1H, CH2), 2.40 (s, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ = 169.1, 167.8, 166.6, 154.7, 135.0, 130.9, 125.1, 124.0, 121.3, 110.7, 
65.1, 64.9, 63.8, 53.2, 53.1, 34.9, 18.0; 
IR (film): ?̃? 2977 (w), 2277 (w), 1788 (w), 1748 (s), 1557 (m), 1487 (w), 1282 (s), 1254 (s), 1216 (s), 1175 
(s), 1105 (m), 1024 (m), 930 (m) cm-1; 
HRMS (ESI) calcd. for C21H20N3O8+ [M+H]+ 442.1245; found 442.1251. 
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12. Product modification 
 
Dimethyl 1,2,4,5-tetrahydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (SI-75). 
 
Pd(OH)2/C (3 mg, 20% Pd, 10%w/w) was added to a solution of 17 (30 mg, 70 µmol) in CH3OH (0.4 mL, 
0.17 M), the mixture was purged with H2 and stirred for 18 hours. Thereafter the mixture was filtered 
through a plug of celite® and concentrated. The residue product was purified by column 
chromatograohy (SiO2, pentane:EtOAc 50:1) and 14 mg (50 µmol, 70%) of the title compound SI-75 
were isolated as a yellow oil. 
Rf: 0.8 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.10 – 7.04 (m, 1H, ArH), 6.98 (d, J = 7.4 Hz, 1H, ArH), 6.59 (td, J = 7.3, 
1.1 Hz, 1H, ArH), 6.39 (dd, J = 8.1, 1.1 Hz, 1H, ArH), 4.03 (dd, J = 11.5, 2.9 Hz, 1H, CH), 3.79 (s, 3H, OCH3), 
3.71 (s, 3H, OCH3), 3.62 (q, J = 8.4 Hz, 1H, CH2), 3.32 (td, J = 9.3, 2.4 Hz, 1H, CH2), 2.99 – 2.87 (m, 1H, 
CH2), 2.80 (ddd, J = 16.2, 4.7, 2.4 Hz, 1H, CH2), 2.73 (ddd, J = 13.1, 7.8, 2.4 Hz, 1H, CH2), 2.34 (ddt, J = 
12.3, 5.1, 2.7 Hz, 1H, CH2), 2.22 (ddd, J = 13.1, 9.6, 8.8 Hz, 1H, CH2), 1.37 (tdd, J = 12.7, 11.6, 4.7 Hz, 1H, 
CH2); 
13C NMR (101 MHz, CDCl3): δ = 170.6, 169.8, 144.1, 128.3, 127.2, 121.0, 115.7, 110.2, 62.1, 61.9, 52.6, 
52.4, 45.7, 31.8, 27.8, 23.9; 
IR (film): ?̃? = 2954 (w), 2925 (w), 2854 (w), 1732 (s), 1605 (m), 1576 (w), 1506 (m), 1480 (w), 1460 (m), 
1436 (m), 1365 (w), 1314 (m), 1270 (s), 1221 (m), 1199 (m), 1172 (m), 1090 (s) cm-1; 
HRMS (ESI) calcd. for C16H19NNaO4+ [M+Na]+ 312.1206; found 312.1205. 
 
(3S,3aR)-methyl 1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline-3-carboxylate (62). 
 
LiCl (37 mg, 0.86 mmol) was added to a solution of SI-75 (50 mg, 0.17 mmol) in DMSO:H2O 10:1 
(0.88 mL, 0.2 M) at room temperature and the resulting mixture was then heated for 5 hours to 140 °C. 
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The mixture was cooled to room temperature, quenched with sat. aq. NH4Cl (5 mL) and extracted with 
DCM (3x15 mL). The combined org. extracts were washed with brine (10 mL) and dried over MgSO4. 
The drying agent was filtered off and the solvent was evaporated. The residue was purified by column 
chromatograohy (SiO2, pentane:EtOAc 50:1) and 34 mg (0.15 mmol, 85%) of the title compound 62 
were isolated as a yellow oil. 
Rf: 0.5 (silica, pentane:EtOAc 20:1); 
1H NMR (400 MHz, CDCl3): δ = 7.15 – 7.04 (m, 1H, ArH), 7.00 (d, J = 7.3 Hz, 1H, ArH), 6.60 (t, J = 7.3 Hz, 
1H, ArH), 6.41 (d, J = 8.1 Hz, 1H, ArH), 3.75 (s, 3H, OCH3), 3.65 – 3.53 (m, 1H, N-CH), 3.43 (td, J = 9.1, 
2.3 Hz, 1H, N-CH2), 3.31 (td, J = 9.3, 7.5 Hz, 1H, N-CH2), 2.86 (m, 1H, Ar-CH2), 2.78 (m, 1H, Ar-CH2), 2.67 
(m, 1H, CH-COOMe), 2.41 – 2.19 (m, 3H, CH2), 1.56 – 1.41 (m, 1H, CH2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 173.4, 144.1, 128.5, 127.2, 121.3, 115.8, 110.2, 60.5, 51.9, 50.0, 46.4, 
27.8, 27.6, 26.4 ppm; 
IR (film): ?̃? = 2952 (w), 2849 (w), 1737 (s), 1605 (m), 1506 (m), 1460 (w), 1352 (m), 1312 (w), 1279 (w), 
1204 (w), 1054 (w), 1021 (w) cm-1; 
HRMS (ESI) calcd. for C14H18NO2+ [M+H]+ 232.1332; found 232.1339. 
 
rac-(1R,3aS,4S,5R)-Dimethyl 4,5-diacetoxy-1-(1,3-dioxoisoindolin-2-yl)-1,2,4,5-
tetrahydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (SI-76). 
 
OsO4 (0.38 mL, 60 µmol, 4% in water, 5 mol%) was added to a solution of 17 (510 mg, 1.18 mmol, 
1 equiv.) and NMO∙H2O (261 mg, 1.93 mmol, 1.2 equiv.) in THF:acetone:water (2:2:1, 5.0 mL, 0.23 M) 
at room temperature and the resulting mixture was stirred for 18 hours. The reaction was diluted with 
water (10 mL) and extracted with EtOAc (3 x 15 mL). The combined org. extracts were washed with 
brine and dried over MgSO4. The drying agent was filtered off and the solution was concentrated. The 
crude product was dissolved in CH2Cl2 (2.0 mL, 0.58 M), DMAP (14 mg, 0.12 mmol, 0.1 equiv.), NEt3 
(0.66 mL, 4.7 mmol, 4 equiv.) and Ac2O (0.33 mL, 3.5 mmol, 3 equiv.) were added and the resulting 
mixture was stirred for 16 hours. The reaction was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with CH2Cl2 (3 x 15 mL). The combined org. extracts were washed with brine (15 mL) and dried over 
MgSO4. The drying agent was filtered off and the solvent was evaporated. The residue was purified by 
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column chromatography (silica, pentane:EtOAc 2:1) and 0.46 g (0.84 mmol, 71%) of the title compound 
SI-76 were isolated as a colorless oil. 
Rf: 0.3 (silica, pentane:EtOAc 1:1); 
1H NMR (400 MHz, CDCl3): δ = 7.82 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.71 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.22 (dd, J = 7.5, 1.6 Hz, 1H, ArH), 7.14 (ddd, J = 8.7, 7.5, 1.6 Hz, 1H, ArH), 6.67 (td, J = 7.4, 1.0 Hz, 1H, 
ArH), 6.55 (d, J = 8.2 Hz, 1H, ArH), 6.32 (dd, J = 8.4, 6.0 Hz, 1H, CH-Phth), 6.14 (d, J = 3.0 Hz, 1H, Ar-CH-
OAc), 5.41 (d, J = 11.4 Hz, 1H, CH-N), 5.05 (dd, J = 11.4, 3.0 Hz, 1H, CH-OAc), 3.82 (s, 3H, OCH3), 3.70 (s, 
3H, OCH3), 3.29 (dd, J = 13.5, 8.3 Hz, 1H, CH2), 2.79 (dd, J = 13.5, 6.0 Hz, 1H, CH2), 2.14 (s, 3H, OAc), 2.06 
(s, 3H, OAc); 
13C NMR (101 MHz, CDCl3): δ = 170.6, 169.8, 169.2, 168.8, 167.6, 140.3, 134.3, 131.8, 131.5, 131.1, 
123.6, 117.9, 117.5, 110.8, 69.3, 68.8, 62.9, 61.3, 60.0, 53.3, 52.8, 38.2, 21.3, 20.7; 
IR (film): ?̃? = 3016 (w), 2951 (w), 1742 (s), 1716 (s), 1610 (w), 1500 (w), 1374 (m), 1266 (s), 1243 (m), 
1222 (m), 1188 (w), 1139 (w), 1053 (s), 1025 (m), 968 (w), 913 (w) cm-1; 
HRMS (ESI) calcd. for C28H26N2NaO10+ [M+Na]+ 573.1480; found 573.1490. 
 
rac-(1S,3aS,4S,5R)-Dimethyl 4,5-diacetoxy-1-vinyl-1,2,4,5-tetrahydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (63). 
 
Vinylmagnesium bromide (0.47 mL, 0.33 mmol, 0.7 M in THF, 4 equiv.) was added dropwise to a 
solution of dry ZnCl2 (0.11 g, 0.82 mmol, 10 equiv.) in THF (1 mL) and the resulting mixture was stirred 
for 10 minutes at room temperature. Thereafter a solution of SI-76 (45 mg, 82 µmol, 1 equiv.) in THF 
(3.5 mL) was added dropwise and the resulting mixture was heated to 50 °C for 18 hours. Thereafter, 
the reaction was cooled to room temperature and quenched with sat. aq. NH4Cl (10 mL). The mixture 
was extracted with CH2Cl2 (3 x 20 mL), the combined org. extracts were washed with brine (20 mL) and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. The residue was 
purified by column chromatography (silica, pentane:EtOAc 3:1) and 24 mg (0.056 mmol, 68%) of the 
title compound 63 were isolated as a colorless oil. 
Rf: 0.6 (silica, pentane:EtOAc 1:1); 
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1H NMR (400 MHz, CDCl3): δ = 7.23 – 7.11 (m, 2H, ArH), 6.65 (td, J = 7.4, 1.0 Hz, 1H, ArH), 6.56 (d, J = 
8.2 Hz, 1H, ArH), 6.15 (d, J = 3.0 Hz, 1H, Ar-CH-OAc), 5.77 (ddd, J = 17.1, 10.2, 7.0 Hz, 1H, CH=CH2), 5.31 
(dt, J = 17.2, 1.1 Hz, 1H, CH=CH2), 5.24 (dt, J = 10.2, 1.1 Hz, 1H, CH=CH2), 5.13 (dd, J = 11.3, 3.0 Hz, 1H, 
CH-CH-OAc), 4.76 (d, J = 11.3 Hz, 1H, N-CH-CHOAc), 4.47 (q, J = 7.6 Hz, 1H, N-CH-CH=CH2), 3.78 (s, 3H, 
OCH3), 3.68 (s, 3H, OCH3), 3.07 (dd, J = 13.1, 7.7 Hz, 1H, CH2), 2.15 (dd, J = 13.1, 8.0 Hz, 1H, CH2), 2.10 
(s, 3H, OAc), 2.01 (s, 3H, OAc). 
13C NMR (101 MHz, CDCl3): δ = 170.4, 169.8, 169.6, 169.0, 142.7, 138.5, 131.3, 130.5, 116.9, 116.8, 
116.5, 111.9, 69.4, 69.1, 60.4, 60.2, 60.1, 53.1, 52.8, 41.1, 21.3, 20.7; 
IR (film): ?̃? = 2675 (w), 2350 (w), 1739 (s), 1610 (w), 1498 (w), 1372 (w), 1261 (m), 1242 (m), 1224 (m), 
1179 (w), 1060 (s), 1026 (m), 954 (w), 912 (m) cm-1; 
HRMS (ESI) calcd. for C22H26NO8+ [M+H]+ 432.1653; found 432.1652. 
 
anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3,8,8a-tetrahydroindolizine-1,1(7H)-
dicarboxylate (64). 
 
Pd(OH)2/C (12 mg, 10%w/w, 20% Pd) was added to a solution of 49 (0.12 mg, 0.30 mmol) in methanol 
(3 mL), the mixture was purged with hydrogen and then stirred for 8 hours under hydrogen 
atmosphere. The mixture was filtered through a plug of Celite®, concentrated and the residue was 
purified by column chromatography (silica, pentane:EtOAc 2:1) affording 88 mg (0.22 mmol, 73%) of 
the title compound 64. 
Rf: 0.2 (silica, pentane:EtOAc 2:1); 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.77 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.74 (d, J = 1.6 Hz, 1H, N-CH=C(CN)), 6.02 (dd, J = 8.2, 6.6 Hz, 1H, CH-Phth), 4.35 (dd, J = 11.4, 3.3 Hz, 
1H, N-CH-CH2), 3.81 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.89 (qd, J = 14.0, 7.4 Hz, 2H, CH2), 2.42 – 2.29 
(m, 2H, CH2), 2.27 – 2.18 (m, 1H, CH2), 1.24 – 1.13 (m, 1H, CH2); 
13C NMR (101 MHz, CDCl3): δ = 169.5, 168.9, 167.5, 141.2, 134.7, 131.3, 123.7, 121.6, 77.6, 65.0, 62.2, 
59.8, 53.0, 52.9, 34.7, 23.4, 22.5; 
IR (film): ?̃? = 2955 (w), 2854 (w), 2193 (m), 1776 (w), 1733 (s), 1714 (s), 1623 (s), 1438 (w), 1397 (w), 
1353 (m), 1324 (m), 1272 (m), 1219 (w), 1151 (m), 1106 (m), 972 (w), 913 (m) cm-1; 
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HRMS (ESI) calcd. for C21H20N3O6+ [M+H]+ 410.1347; found 410.1348. 
 
rac-(3R,7R,8S,8aS)-Dimethyl 7,8-bis((tert-butyldimethylsilyl)oxy)-6-cyano-3-(1,3-dioxoisoindolin-2-
yl)-2,3,8,8a-tetrahydroindolizine-1,1(7H)-dicarboxylate (65). 
 
OsO4 (0.21 mL, 0.026 mmol, 4% in water, 5 mol%) was added to a solution of 49 (214 mg, 0.525 mmol, 
1 equiv.) and NMO∙H2O (85 mg, 0.63 mmol, 1.2 equiv.) in acetone:water 20:1 (5.25 mL, 0.1 M) at 0 °C. 
The resulting mixture was stirred for 16 hours, while warming to room temperature, then the solvent 
was evaporated and the residue was dried in high vacuo. The residue was suspended in CH2Cl2 (2.5 mL) 
and pyridine (0.21 mL, 2.6 mmol, 5 equiv.) followed by TBSOTf (0.48 mL, 2.1 mmol, 4 equiv.) were 
added. The resulting mixture was stirred for 18 hours at room temperature and thereafter quenched 
with sat. aq. NH4Cl (10 mL). The mixture was extracted with Et2O (3 x 15 mL), the combined org. 
extracts were washed with brine (10 mL) and then dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated. The residue was purified by column chromatography (silica, 
pentane:EtOAc 4:1) affording 231 mg (0.345 mmol, 66%) of the title compound 65 as a colorless oil. 
Rf: 0.2 (silica, pentane:EtOAc 4:1); 
1H NMR (400 MHz, CDCl3): δ = 7.87 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.78 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 
6.75 (s, 1H, N-CH=C(CN)), 6.03 (t, J = 7.8 Hz, 1H, CH-Phth), 5.09 (d, J = 10.4 Hz, 1H, N-CH-CH(OTBS)), 
4.27 (d, J = 2.4 Hz, 1H, C(CN)-CH(OTBS)), 3.82 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.72 (dd, J = 10.4, 2.4 
Hz, 1H, (CN)C-CH-CH-CHN), 3.06 (dd, J = 13.2, 7.8 Hz, 1H, CH2), 2.96 (dd, J = 13.2, 7.8 Hz, 1H, CH2), 0.92 
(s, 9H, C(CH3)3), 0.89 (s, 9H, C(CH3)3), 0.15 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3), -0.06 (s, 
3H, SiCH3) ppm; 
13C NMR (101 MHz, CDCl3): δ = 169.0, 168.2, 167.0, 143.6, 134.8, 131.3, 123.8, 121.1, 80.2, 70.7, 67.8, 
64.9, 61.2, 61.0, 53.0, 52.9, 36.5, 25.9, 25.5, 18.1, 17.9, -3.2, -3.5, -4.8, -5.5 ppm; 
IR (film): ?̃? = 2954 (w), 2930 (w), 2894 (w), 2857 (w), 2195 (w), 1720 (s), 1618 (s), 1472 (w), 1360 (w), 
1255 (m), 1133 (m), 1109 (m), 958 (m), 913 (m), 840 (s) cm-1; 
HRMS (ESI) calcd. for C33H47N3NaO8Si2+ [M+Na]+ 692.2794; found 692.2797. 
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13. Attempts towards the Enantioselective Dearomatization 
Table S8 Screening of chiral ligands for the annulation reaction. 
 
Entry Lewis Acid Ligand Solvent Yield ee 
1 Yb(OTf)3 L1 CH2Cl2 88% 0% 
2 Sc(OTf)3 L1 CH2Cl2 90% 12% 
3 Sc(OTf)3 L1 PhCl 56% 9% 
4 MgI2 L1 CH2Cl2 81% 6% 
5 La(OTf)3 L1 CH2Cl2 91% 10% 
6 La(OTf)3 L1 THF 84% 10% 
7 Zn(OTf)2 L1 CH2Cl2 no conversion - 
8 Zn(NTf2)2 L1 CH2Cl2 9% 18% 
9 Sc(OTf)3 L2 CH2Cl2 55% 1% 
10 Sc(OTf)3 L3 CH2Cl2 35% 1% 
11 Sc(OTf)3 L4 CH2Cl2 44% 2% 
12 Cu(OTf)2 L5 CH2Cl2 no conversion - 
13 Ni(OTf)2 L5 CH2Cl2 93% 6% 
14 Zn(OTf)2 L5 CH2Cl2 83% 10% 
15 Yb(OTf)3 L6 CH2Cl2 93% 0% 
16 Yb(OTf)3 L7 CH2Cl2 87% 0% 
17 Sc(OTf)3 L7 CH2Cl2 85% 0% 
18 Yb(OTf)3 L8 CH2Cl2 83% 0% 
19 Sc(OTf)3 L8 CH2Cl2 88% 0% 
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General procedure for the attempted enantioselective dearomatization 
A vial was charged with the ligand (0.06 mmol, 6 mol%) and the Lewis acid (0.05 mmol, 5 mol%) in the 
glovebox, then CH2Cl2 (0.1 mL) was added and the resulting mixture was stirred for 3 hours at room 
temperature. Thereafter a solution of the cyclopropane 14 in CH2Cl2 (0.1 mL) was added, followed by 
quinoline 8 (0.10 mmol, 1.00 equiv.) and stirring of the mixture was continued for 16 hours at room 
temperature. The solvent was then evaporated and the residue was purified by column 
chromatography (silica, pentane:EtOAc 10:1 to 4:1). The enantiomeric excess was determined by chiral 
HPLC. Chiralcel IA, hexane:iPrOH 60:40, 1 mL/min, 31 min, tR1 = 10.2 min, tR2 14.4 min, λ = 254 nm. 
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14. Spectra of new compounds 
 
1-tert-Butyl 1-methyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (SI-32). 
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5-(Quinolin-3-yl)pent-4-yn-1-yl acetate (SI-38). 
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3-(5-((tert-Butyldimethylsilyl)oxy)pent-1-yn-1-yl)quinoline (SI-39). 
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4-(5-Hydroxypent-1-yn-1-yl)nicotinonitrile (SI-50). 
  
82 
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4-(5-((tert-Butyldimethylsilyl)oxy)pent-1-yn-1-yl)nicotinonitrile (SI-51). 
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4-(5-((tert-Butyldimethylsilyl)oxy)pentyl)nicotinonitrile (SI-52). 
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anti-Dimethyl 1,2,4,5-tetrahydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (17). 
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anti-Dimethyl 5-chloro-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (20). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-5-methyl-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (21). 
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(1R,3aR)-Dimethyl 5-((S)-acetoxy((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methyl)-1-(1,3-
dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (22a) and (1S,3aS)-
dimethyl 5-((S)-acetoxy((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methyl)-1-(1,3-dioxoisoindolin-2-yl)-
1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (22b). 
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anti-Dimethyl 4-bromo-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (23). 
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anti-Dimethyl 4-(5-acetoxypent-1-yn-1-yl)-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-
a]quinoline-3,3(3aH)-dicarboxylate (24). 
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95 
 
anti-Dimethyl 4-(5-((tert-butyldimethylsilyl)oxy)pent-1-yn-1-yl)-1-(1,3-dioxoisoindolin-2-yl)-1,2-
dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (25). 
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anti-Dimethyl 7-bromo-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (26). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-fluoro-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (27). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-phenyl-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (28). 
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anti-Trimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3,7(3aH)-
tricarboxylate (29). 
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anti-Dimethyl 7-cyano-1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (30). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-9-fluoro-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (31). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-8-(trifluoromethyl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (32). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-7-methoxy-6-nitro-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (34). 
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anti-Dimethyl 1-(5,6-dichloro-1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (35). 
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anti-Dimethyl 1-(5-nitro-1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (36). 
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anti-Dimethyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (37). 
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anti-Dimethyl 1-(2,5-dioxopyrrolidin-1-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (38). 
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anti-Dimethyl 1-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (39). 
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anti-Dibenzyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (40). 
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anti-bis(2,2,2-Trifluoroethyl) 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (41). 
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(1R,3S,3aR)-3-tert-Butyl 3-methyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (42a). 
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(1R,3R,3aR)-3-tert-Butyl 3-methyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydropyrrolo[1,2-a]quinoline-
3,3(3aH)-dicarboxylate (42b).
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124 
 
anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-1,1(10bH)-
dicarboxylate (43). 
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anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-
1,1(10bH)-dicarboxylate (44). 
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127 
 
anti-Trimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydropyrrolo[2,1-a]isoquinoline-1,1,6(10bH)-
tricarboxylate (45). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydrobenzo[d]pyrrolo[2,1-b]thiazole-3,3(3aH)-
dicarboxylate (46). 
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anti-Dimethyl 1-(1,3-dioxoisoindolin-2-yl)-1,2-dihydrobenzo[d]pyrrolo[2,1-b]oxazole-3,3(3aH)-
dicarboxylate (47). 
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anti-Dimethyl 7-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(48). 
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133 
 
anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(49). 
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anti-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-7-methyl-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (50). 
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anti-Dimethyl 7-bromo-6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (51). 
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anti-Dimethyl 7-(5-((tert-butyldimethylsilyl)oxy)pentyl)-6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3-
dihydroindolizine-1,1(8aH)-dicarboxylate (52). 
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anti-6,7-Diethyl 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6,7(8aH)-
tetracarboxylate (54). 
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anti-6,8-Diethyl 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6,8(8aH)-
tetracarboxylate (55). 
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anti-6-(1,1,1,3,3,3-Hexafluoropropan-2-yl) 1,1-dimethyl 3-(1,3-dioxoisoindolin-2-yl)-2,3-
dihydroindolizine-1,1,6(8aH)-tricarboxylate (56). 
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anti-Trimethyl 3-(1,3-dioxoisoindolin-2-yl)-7-(trifluoromethyl)-2,3-dihydroindolizine-1,1,6(8aH)-
tricarboxylate (57). 
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anti-Trimethyl 7-chloro-3-(1,3-dioxoisoindolin-2-yl)-2,3-dihydroindolizine-1,1,6(8aH)-tricarboxylate 
(58). 
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anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-6-nitro-2,3-dihydroindolizine-1,1(8aH)-dicarboxylate 
(59). 
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anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-7-methyl-6-nitro-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (60). 
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anti-Dimethyl 3-(1,3-dioxoisoindolin-2-yl)-5-methyl-6-nitro-2,3-dihydroindolizine-1,1(8aH)-
dicarboxylate (61). 
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Dimethyl 1,2,4,5-tetrahydropyrrolo[1,2-a]quinoline-3,3(3aH)-dicarboxylate (SI-75). 
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(3S,3aR)-methyl 1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline-3-carboxylate (62).  
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(1R,3aS,4S,5R)-Dimethyl 4,5-diacetoxy-1-(1,3-dioxoisoindolin-2-yl)-1,2,4,5-tetrahydropyrrolo[1,2-
a]quinoline-3,3(3aH)-dicarboxylate (SI-76). 
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(1S,3aS,4S,5R)-Dimethyl 4,5-diacetoxy-1-vinyl-1,2,4,5-tetrahydropyrrolo[1,2-a]quinoline-3,3(3aH)-
dicarboxylate (63). 
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(3R,8aR)-Dimethyl 6-cyano-3-(1,3-dioxoisoindolin-2-yl)-2,3,8,8a-tetrahydroindolizine-1,1(7H)-
dicarboxylate (64). 
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(3R,7R,8S,8aS)-Dimethyl 7,8-bis((tert-butyldimethylsilyl)oxy)-6-cyano-3-(1,3-dioxoisoindolin-2-yl)-
2,3,8,8a-tetrahydroindolizine-1,1(7H)-dicarboxylate (65). 
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